Author: "M, Mathieu" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"M, Mathieu"' showing total 1,366 results

Start Over Author "M, Mathieu"

1,366 results on '"M, Mathieu"'

51. Les collectivités territoriales et la question prioritaire de constitutionnalité

Author: GODDAER, A. (Anthony), MAURICE, M. (Mathieu), Université de Lille, and Centre de recherche Droits et perspectives du droit - ULR 4487 [CRDP]
Abstract: Etude réalisée dans le cadre du M2 Droit public général et contentieux publics, en liaison avec le rapport sur Les justiciables de la QPC (QPC2020) remis au Conseil constitutionnel le 15 janvier 2020, dirigé par le professeur Emmanuel Cartier (Université de Lille). Study carried out as part of the Master 2 General Public Law and Public Litigation, in connection with the report on "Les justiciables de la QPC" (QPC2020) submitted to the Constitutional Council on 15 January 2020, managed by professor Emmanuel Cartier (University of Lille)
Published: 2020

52. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Author: Bousquet, J. Akdis, C.A. Jutel, M. Bachert, C. Klimek, L. Agache, I. Ansotegui, I.J. Bedbrook, A. Bosnic-Anticevich, S. Canonica, G.W. Chivato, T. Cruz, A.A. Czarlewski, W. Del Giacco, S. Du, H. Fonseca, J.A. Gao, Y. Haahtela, T. Hoffmann-Sommergruber, K. Ivancevich, J.-C. Khaltaev, N. Knol, E.F. Kuna, P. Larenas-Linnemann, D. Mullol, J. Naclerio, R. Ohta, K. Okamoto, Y. O’Mahony, L. Onorato, G.L. Papadopoulos, N.G. Pfaar, O. Samolinski, B. Schwarze, J. Toppila-Salmi, S. Ventura, M.-T. Valiulis, A. Yorgancioglu, A. Zuberbier, T. Pawankar, R. Mubeccel, A. Mona, A.-A. Emilio, A.C. Hasan, A. Cristina, A.M. Zeinab, A. Mostafa, B.E. Sergio, B. Cristina, B. Eric, B. Bianca, B. Elisabeth, B. Larl-Christian, B. David, B. Leif, B. Attilio, B. Sergio, B. isabelle, B. Jacques, B. Louis-Philippe, B. Fulvio, B. Christopher, B. Roland, B. Carmen, B. Andrew, B. William, B. Fernan, C.-F. Davide, C. Silvia, C. Paulo, C. Walter, C. Vicky, C. Kai-Hakon, C. Warner, C. Thomas, C. Lorenzo, C. Alfonso, C.M. Niels, C. Ekaterine, C. George, C. Derek, C. Cemal, C. Giorgio, C. Ieva, C. Sousa Jaime, C.D. Maria del Carmen, C.D. André, C. Linda, C. Alvaro, C. Adnan, C. Ulf, D. Frédéric, D.B. Diana, D. Pascal, D. Philippe, D. Alain, D. Ratko, D. Maria, D.C.T. Dejan, D. Ruta, D. Stephen, D. Patrik, E. Yehia, E.-G. Regina, E. Bieren Julia, E.-V. Alessandro, F. Wytske, F. Mina, G. Luis, G.R.J. Bilun, G. Sonya, G. José, G. Maximiliano, G. Maia, G. Ineta, G. Marta, G. Antonieta, G.M. Adnan, H. Elham, H. Jonathan, H. Martin, H. Yunuen, H.V. Guido, I. Carla, I. Zhanat, I. Edgardo, J. Ewa, J. Erika, J.-J. Sebastian, J. Guy, J. Ki-Suck, J. Jocelyne, J. Igor, K. Omer, K. Fuat, K. Przemyslaw, K. Jussi, K. Jorg, K.-T. Gerard, K. Marek, K. Mikael, K. Violeta, K. Amir, L. Susanne, L. Lan, L. Marcus, L. Michael, L. Jing, L. Philip, L. Brian, L. Karin, L.C. Bassam, M. Mika, M. Hans-Jorgen, M. Gailen, M. Pedro, M. Mohammad, M. Juan-José, M. Cem, M. Erik, M. Eli, M. Hans, M. Jean-Pierre, M. Florin, M. Neven, M. Branislava, M. Yousser, M. Mathieu, M. Mario, M.-A. Ralph, M. Lars, M. Antonella, M. Tihomir, M. Alla, N. Leyla, N.-B. Kristof, N. Laurent, N. Robyn, O. Kimihiro, O. Brian, O. Luigi, P.P. Isabella, P.-S. Petr, P. Nilos, P. Sim, P.H. Ruby, P. Ana, P. Bernard, P. Constantinos, P. Davor, P. Wolfgang, P. Todor, P. Fabienne, P. Paul, P. Lars, P. Emmanuel, P. Claus, R. Stella, R.M. Janet, R. José Angelo, R. Graham, R. Nicolas, R. Antonino, R. Jose, R.-P. Nelson, R. Lanny, R. Philip, R. Dermot, R. Mario, S.-B. Joaquin, S.-D. Glenis, S. Elie, S. Nikolaos, S. Estelle, S. Juan-Carlos, S. Dirceu, S. Talant, S. Manuel, S.-M. Cristiana, S. Rafael, S. Timo, S. Charlotte, S.U. Carel, T. Peter-Valentin, T. Massimo, T. Ioana, T. Marilyn, U.P. Erkka, V. Eric, V.G. Marianne, V.H. Olivier, V. Petra, V. Martin, W. Dana, W. Yun, W.D. Susan, W. Magnus, W. Dennis, W. Barbara, Y. Arzu, Y. Osman, Y. Mario, Z. Mihaela, Z. the ARIA-MASK Study Group
Published: 2020

53. ICES. 2020. Working Group on Acoustic and Egg Surveys for Sardine and Anchovy in ICES areas 7, 8 and 9

Author: Amorin, Pedro, Boyra, G. (Guillermo), Carrera, P. (Pablo), Díaz-Conde, M.P. (María Paz), O'Donnell, C. (Ciaran), Doray, M. (Mathieu), Duhamel, E. (Erwan), Huret, M. (Martin), Ibaibarriaga, L. (Leire), Jiménez, M.P. (María Paz), Angélico, M.M. (María Manuel), Moreno, A. (Ana), Nunes, C. (Cristina), Pawlowski, L. (Lionel), Ramos, F. (Fernando), Riveiro, I. (Isabel), Rodriguez, S. (Silvia), Santos, Maria, Silva, A. (Alexandra), Uriarte, A. (Andrés), and Jeroen, Vankooij
Abstract: he Working Group on Acoustic and Egg Surveys (WGACEGG) coordinates pelagic surveys for a number of stocks and provides monitoring for the two major sardine and anchovy stocks in ICES areas 6, 7, 8, and 9. The group evaluated small pelagic fish biomass indices derived from acoustic and Daily Egg Production Method (DEPM) surveys in ICES areas 6, 7, 8 and 9. These indices have been provided to the ICES Working Group on Southern Horse Mackerel, Anchovy and Sardine (WGHANSA), the Working Group on Widely Distributed Stocks (WGWIDE) and the Herring Assessment Working Group for the Area South of 62ºN (HAWG) stock assessment group, to serve as fishery-independent input for analytical assessment purposes. DEPM and acoustic indices were derived based on data collected using independent methods. Acoustic- and DEPM-derived biomass indices from quasi-synoptic surveys conducted in the Bay of Biscay in spring were compared, to assess the presence of potential bias and to improve the precision of fish stock biomass estimates. The DEPM-based anchovy biomass index was 22% higher than the acoustic index in 2019. Unusual concentrations of anchovy in Eastern Cantabrian Sea, an area not covered by the acoustic survey, and the presence near the sea surface of actively spawning individuals possibly under-sampled by acoustics in central Bay of Bay had been postulated as potential causes of this discrepancy. No significant difference was found between sardine biomass indices derived from DEPM and acoustics in 2019. The group has updated its database of standard gridded maps covering the European Atlantic area. This initiative continues to inform on the spatial dynamics of various parameters collected during the surveys coordinated under the auspices of the group (fish acoustic densities, anchovy and sardine egg abundance, surface temperature and salinity). Results of an analysis of the time series of gridded maps (anchovy and sardine acoustic density, surface salinity and temperature) showed quantitative changes in the spatial and temporal distribution of anchovy and sardine over the last 15 years, and further define their habitats in European Atlantic waters in spring. The timing and spatial coverage of DEPM and acoustic surveys that will be conducted by group members in 2020 were planned to optimise the monitoring of anchovy and sardine populations and their pelagic environment in the European Atlantic area. The synoptic nature of the survey components has been assessed for each target species. A manual describing the protocols used during the DEPM surveys coordinated by the WGACEGG group was reviewed, and writing of a manual of WGACEGG acoustic surveys continued. Both manuals will be available in 2020. The final results of the 2017 sardine DEPM assessment were endorsed by the group.
Published: 2020

54. 'I'm sorry Dave, I'm afraid I can't do that' Deep Q-Learning From Forbidden Actions

Author: Seurin, M. (Mathieu), Preux, P. (Philippe), Pietquin, O. (Olivier), Université de Lille, Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189 (CRIStAL), Université de Lille-Ecole Centrale de Lille-Centre National de la Recherche Scientifique (CNRS), Sequential Learning (SEQUEL), Inria Lille - Nord Europe, Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189 (CRIStAL), Université de Lille-Ecole Centrale de Lille-Centre National de la Recherche Scientifique (CNRS)-Université de Lille-Ecole Centrale de Lille-Centre National de la Recherche Scientifique (CNRS), Google Brain, Paris, Seurin, Mathieu, Centrale Lille-Université de Lille-Centre National de la Recherche Scientifique (CNRS), Centrale Lille-Université de Lille-Centre National de la Recherche Scientifique (CNRS)-Centrale Lille-Université de Lille-Centre National de la Recherche Scientifique (CNRS), Scool (Scool), Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189 [CRIStAL], and Sequential Learning [SEQUEL]
Subjects: [INFO.INFO-AI] Computer Science [cs]/Artificial Intelligence [cs.AI], Deep Reinforcement Learning, [INFO.INFO-LG]Computer Science [cs]/Machine Learning [cs.LG], [INFO.INFO-NE] Computer Science [cs]/Neural and Evolutionary Computing [cs.NE], [INFO.INFO-LG] Computer Science [cs]/Machine Learning [cs.LG], Safety, [INFO.INFO-NE]Computer Science [cs]/Neural and Evolutionary Computing [cs.NE], constraints, Q-Learning, [INFO.INFO-AI]Computer Science [cs]/Artificial Intelligence [cs.AI]
Abstract: International audience; The use of Reinforcement Learning (RL) is still restricted to simulation or to enhance human-operated systems through recommendations. Real-world environments (e.g. industrial robots or power grids) are generally designed with safety constraints in mind implemented in the shape of valid actions masks or contingency controllers. For example, the range of motion and the angles of the motors of a robot can be limited to physical boundaries. Violating constraints thus results in rejected actions or entering in a safe mode driven by an external controller, making RL agents incapable of learning from their mistakes. In this paper, we propose a simple modification of a state-of-the-art deep RL algorithm (DQN), enabling learning from forbidden actions. To do so, the standard Q-learning update is enhanced with an extra safety loss inspired by structured classification. We empirically show that it reduces the number of hit constraints during the learning phase and accelerates convergence to near-optimal policies compared to using standard DQN. Experiments are done on a Visual Grid World Environment and Text-World domain.
Published: 2019

55. BUBR1 Pseudokinase Domain Promotes Kinetochore PP2A-B56 Recruitment, Spindle Checkpoint Silencing, and Chromosome Alignment

Author: Pauline Garcia, Luciano Gama Braga, Christian R. Landry, Michelle M. Mathieu, Maxime Clerc, Angel F. Cisneros, Philippe Thebault, Sabine Elowe, Chantal Garand, and Baptiste Lottin
Subjects: 0301 basic medicine, Spindle checkpoint, Aurora B kinase, pseudokinase, Mitosis, Cell Cycle Proteins, Spindle Apparatus, Biology, Protein Serine-Threonine Kinases, General Biochemistry, Genetics and Molecular Biology, Chromosomes, 03 medical and health sciences, 0302 clinical medicine, Protein Domains, Humans, Protein Phosphatase 2, Phosphorylation, Kinetochores, lcsh:QH301-705.5, B56, Anaphase, Kinetochore, Protein phosphatase 2, Cell Cycle Checkpoints, PP2A, Cell biology, Spindle apparatus, BUBR1, 030104 developmental biology, lcsh:Biology (General), M Phase Cell Cycle Checkpoints, 030217 neurology & neurosurgery, HeLa Cells, Protein Binding
Abstract: Summary: The balance of phospho-signaling at the outer kinetochore is critical for forming accurate attachments between kinetochores and the mitotic spindle and timely exit from mitosis. A major player in determining this balance is the PP2A-B56 phosphatase, which is recruited to the kinase attachment regulatory domain (KARD) of budding uninhibited by benzimidazole 1-related 1 (BUBR1) in a phospho-dependent manner. This unleashes a rapid, switch-like phosphatase relay that reverses mitotic phosphorylation at the kinetochore, extinguishing the checkpoint and promoting anaphase. Here, we demonstrate that the C-terminal pseudokinase domain of human BUBR1 is required to promote KARD phosphorylation. Mutation or removal of the pseudokinase domain results in decreased PP2A-B56 recruitment to the outer kinetochore attenuated checkpoint silencing and errors in chromosome alignment as a result of imbalance in Aurora B activity. Our data, therefore, elucidate a function for the BUBR1 pseudokinase domain in ensuring accurate and timely exit from mitosis.
Published: 2019

56. P1247FLNC pathogenic variants in patients with various cardiomyopathies:prevalence and genotype-phenotype correlations

Author: P. Charron, Y. Troadec, Flavie Ader, Laurent Gouya, Eric Villard, Xavier Jeunemaitre, P. Richard, M. Mathieu Dramard, Diala Khraiche, Delphine Dupin-Deguine, P. De Groote, L. Van Maldergem, Jean François Pruny, P. Reant, and Caroline Rambaud
Subjects: Genetics, business.industry, Medicine, In patient, Cardiology and Cardiovascular Medicine, business, Genotype-Phenotype Correlations
Abstract: Background/Introduction Pathogenic variants FLNC encoding filamin C have been firstly reported to cause myopathies, and were recently linked to isolated cardiac phenotypes.However, few data on phenotype-genotype correlation are available. Purpose Our aim was to estimate the prevalence of FLNC pathogenic variants in cardiomyopathies and to study the relations between phenotype and genotype. Methods DNAs from a cohort of 1150 unrelated index-patients with an isolated cardiomyopathy (700 hypertrophic, 300 dilated, 50 restrictive cardiomyopathies, and 100 left ventricle non-compactions) have been sequenced on a custom panel of 52 cardiomyopathy disease-causing genes. Results A FLNC pathogenic variant was identified in 28 patients corresponding to a prevalence ranging from 1 to 8% depending on the cardiomyopathy subtypes. Truncating variants were always identified in patients with dilated cardiomyopathy, while missense or in-frame variants were found in other phenotypes. This work reported for the first time a left ventricular non-compaction associated with FLNC pathogenic variant. In the cohort, nine patients (32%) were implanted with an automatic defibrillator. In 7 families (25%), history of sudden cardiac death (SCD) before 50 years was reported. A personal or family history of sudden cardiac death (SCD) was significantly higher in patients with truncating variants than in patients carrying missense variants (p=0.01). Four patients died of cardiac cause including 3 from SCD and 1 from heart failure. Conclusion This work highlights the role of FLNC in cardiomyopathies. A correlation between the type of the variant and the cardiomyopathy subtype was observed as well as with SCD risk. These new data should be taken into consideration for patient's management and primary prevention of sudden cardiac death. Acknowledgement/Funding La ligue contre la Cardiomyopathie
Published: 2019
Full Text: View/download PDF

57. The BUBR1 pseudokinase domain promotes efficient kinetochore PP2A-B56 recruitment to regulate spindle checkpoint silencing and chromosome alignment

Author: Sabine Elowe, Chantal Garand, Pauline Garcia, Philippe Thebault, Baptiste Lottin, Maxime Clerc, Luciano Gama Braga, Christian R. Landry, Michelle M. Mathieu, and Angel F. Cisneros
Subjects: 0303 health sciences, Kinetochore, Aurora B kinase, BUB1, Protein phosphatase 2, Biology, Spindle apparatus, Cell biology, 03 medical and health sciences, Spindle checkpoint, 0302 clinical medicine, Mitosis, 030217 neurology & neurosurgery, 030304 developmental biology, Anaphase
Abstract: The balance of phospho-signalling at outer-kinetochores during mitosis is critical for the accurate attachments between kinetochores and the mitotic spindle and timely exit from mitosis. In humans, a major player in determining this balance is the PP2A-B56 phosphatase which is recruited to the Kinase Attachment Regulatory Domain (KARD) of the Spindle Assembly Checkpoint protein Budding Uninhibited by Benzimidazole 1-related 1 (BUBR1) in a phospho-dependent manner. This event unleashes a rapid, switch-like phosphatase relay that reverses phosphorylation at the kinetochore, extinguishing the checkpoint and promoting anaphase entry. Here, we conclusively demonstrate that the pseudokinase domain of human BUBR1 lacks phosphotransfer activity and that it was maintained in vertebrates because it allosterically promotes KARD phosphorylation. Mutation or removal of this domain results in decreased PP2A-B56 recruitment to the outer kinetochore, attenuated checkpoint silencing and errors in chromosome alignment as a result of imbalance in Aurora B activity. We demonstrate that the functions of the BUBR1 pseudokinase and the BUB1 kinase domains are intertwined, providing an explanation for retention of the pseudokinase domain in certain eukaryotes.
Published: 2019
Full Text: View/download PDF

58. Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study

Author: Andelic, N. (Nada), Røe, C. (Cecilie), Brunborg, C. (Cathrine), Zeldovich, M. (Marina), Løvstad, M. (Marianne), Løke, D. (Daniel), Borgen, I.M. (Ida M.), Voormolen, D.C. (Daphne), Howe, E.I. (Emilie I.), Forslund, M.V. (Marit V.), Dahl, H.M. (Hilde M.), Von Steinbuechel, N. (Nicole), Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andreassen, L. (Lasse), Anke, A. (Audny), Antoni, A. (Anna), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Barzo, P. (P.), Beauvais, R. (Romuald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Belli, A. (Antonio), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Blaabjerg, M. (Morten), Bragge, P. (Peter), Brazinova, A. (Alexandra), Brinck, V. (Vibeke), Brooker, J. (Joanne), Brorsson, C. (Camilla), Buki, A. (Andras), Bullinger, M. (Monika), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Carbonara, M. (Marco), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Citerio, G. (Giuseppe), Ceyisakar, I.E. (Iris), Clusmann, H. (Hans), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D), Correia, M. (Marta), Covic, A. (Amra), Curry, N. (Nicola), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), Dawes, H. (Helen), Keyser, V. (Véronique), Degos, V. (Vincent), Corte, F.D. (Francesco Della), Boogert, H. (Hugo), Depreitere, B. (Bart), Đilvesi, Đ. (Đula), Dixit, A. (Abhishek), Donoghue, E. (Emma), Dreier, J.P. (Jens), Dulière, G.-L. (Guy -Loup), Ercole, A. (Ari), Esser, P. (Patrick), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Feigin, V.L. (Valery L), Foks, K. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Gagliardo, P. (Pablo), Galanaud, D. (Damien), Gantner, D. (Dashiell), Gao, G. (Guoyi), George, P. (Pradeep), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Glocker, B. (Ben), Golubovic, J. (Jagoš), Gomez, P.A. (Pedro A), Gratz, J. (Johannes), Gravesteijn, B. (Benjamin), Grossi, F. (Francesca), Gruen, R.L. (Russell), Gupta, D. (Deepak), Haagsma, J.A. (Juanita), Haitsma, I. (Iain), Helbok, R. (Raimund), Helseth, E. (Eirik), Horton, L. (Lindsay), Huijben, J. (Jilske), Hutchinson, P.J. (Peter J.), Jacobs, B.C. (Bart), Jankowski, S. (Stefan), Jarrett, M. (Mike), Jiang, J.-Y. (Ji-Yao), Johnson, F. (Faye), Jones, K.M. (Kelly M.), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kompanje, E.J.O. (Erwin), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Lanyon, L. (Linda), Laureys, S. (Steven), Lecky, F.E. (Fiona), Ledoux, D. (Didier), Lefering, R., Legrand, V. (Valerie), Lejeune, A. (Aurelie), Levi, L. (Leon), Lightfoot, R. (Roger), Lingsma, H.F. (Hester), Maas, A.I.R. (Andrew), Castaño-León, A.M. (Ana M), Maegele, M. (Marc), Majdan, M. (Marek), Manara, A. (Alex), Manley, G. (Geoffrey), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Melegh, B. (Béla), Menon, D.K. (David ), Menovsky, T. (Tomas), Mikolic, A. (Ana), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Nelson, D. (David), Newcombe, V.F. (Virginia F.), Nieboer, D. (Daan), Nyirádi, J. (József), Olubukola, O. (Otesile), Oresic, M. (Matej), Ortolano, F. (Fabrizio), Palotie, A. (Aarno), Parizel, P.M., Payen, J.-F. (Jean-François), Perera, N. (Natascha), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W.C. (Wilco), Piippo-Karjalainen, A. (Anna), Pirinen, M. (Matti), Ples, H. (Horia), Polinder, S. (Suzanne), Pomposo, I. (Inigo), Posti, J.P. (Jussi P), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rambadagalla, M. (Malinka), Rhodes, J.K.J. (Jonathan K.J.), Richardson, S. (Sylvia), Richter, S. (Sophie), Ripatti, S. (Samuli), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosand, J. (Jonathan), Rosenfeld, J.V. (Jeffrey V), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Rueckert, D. (Daniel), Rusnák, M. (Martin), Sahuquillo, J. (Juan), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Sandor, J. (Janos), Schäfer, N. (Nadine), Schmidt, S. (Silke), Schoechl, H. (Herbert), Schoonman, G.G. (Guus), Schou, R. (Rico), Schwendenwein, E. (Elisabeth), Sewalt, C. (Charlie), Skandsen, T. (Toril), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stanworth, S. (Simon), Stevens, R. (Robert), Stewart, W. (William), Steyerberg, E.W. (Ewout), Stocchetti, N. (Nino), Sundström, N. (Nina), Synnot, A. (Anneliese), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Taylor, M.S. (Mark Steven), Ao, B.T. (Braden Te), Tenovuo, O. (Olli), Theadom, A. (Alice), Thomas, M. (Matt), Tibboel, D. (Dick), Timmers, M. (Marjolein), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Maria Tudora, C. (Cristina), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Jagt, M. (Mathieu), Steen, G. (Gregory), Naalt, J. (Joukje), Jeroen, T.J.M.D. (T.J.M. van Dijck), Essen, T.A. (Thomas A.), Hecke, W. (Wim), Heugten, C. (Caroline), Praag, D. (Dominique), Vyvere, T. (Thijs), RoelWijk, P.J. (P. J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Velt, K. (Kimberley), Verheyden, J. (Jan), Vespa, P.M. (Paul M), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Steinbüchel, N. (Nicole), Voormolen, D. (Daphne), Vulekovic, P. (Peter), Wang, K.K.W. (Kevin), Wiegers, E. (Eveline), Williams, G. (Guy), Wilson, L. (Lindsay), Winzeck, S. (Stefan), Wolf, S. (Stefan), Yang, Z. (Zhihui), Ylén, P. (Peter), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Zelinkova, V. (Veronika), Ziverte, A. (Agate), Zoerle, T. (Tommaso), Andelic, N. (Nada), Røe, C. (Cecilie), Brunborg, C. (Cathrine), Zeldovich, M. (Marina), Løvstad, M. (Marianne), Løke, D. (Daniel), Borgen, I.M. (Ida M.), Voormolen, D.C. (Daphne), Howe, E.I. (Emilie I.), Forslund, M.V. (Marit V.), Dahl, H.M. (Hilde M.), Von Steinbuechel, N. (Nicole), Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andreassen, L. (Lasse), Anke, A. (Audny), Antoni, A. (Anna), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Barzo, P. (P.), Beauvais, R. (Romuald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Belli, A. (Antonio), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Blaabjerg, M. (Morten), Bragge, P. (Peter), Brazinova, A. (Alexandra), Brinck, V. (Vibeke), Brooker, J. (Joanne), Brorsson, C. (Camilla), Buki, A. (Andras), Bullinger, M. (Monika), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Carbonara, M. (Marco), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Citerio, G. (Giuseppe), Ceyisakar, I.E. (Iris), Clusmann, H. (Hans), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D), Correia, M. (Marta), Covic, A. (Amra), Curry, N. (Nicola), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), Dawes, H. (Helen), Keyser, V. (Véronique), Degos, V. (Vincent), Corte, F.D. (Francesco Della), Boogert, H. (Hugo), Depreitere, B. (Bart), Đilvesi, Đ. (Đula), Dixit, A. (Abhishek), Donoghue, E. (Emma), Dreier, J.P. (Jens), Dulière, G.-L. (Guy -Loup), Ercole, A. (Ari), Esser, P. (Patrick), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Feigin, V.L. (Valery L), Foks, K. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Gagliardo, P. (Pablo), Galanaud, D. (Damien), Gantner, D. (Dashiell), Gao, G. (Guoyi), George, P. (Pradeep), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Glocker, B. (Ben), Golubovic, J. (Jagoš), Gomez, P.A. (Pedro A), Gratz, J. (Johannes), Gravesteijn, B. (Benjamin), Grossi, F. (Francesca), Gruen, R.L. (Russell), Gupta, D. (Deepak), Haagsma, J.A. (Juanita), Haitsma, I. (Iain), Helbok, R. (Raimund), Helseth, E. (Eirik), Horton, L. (Lindsay), Huijben, J. (Jilske), Hutchinson, P.J. (Peter J.), Jacobs, B.C. (Bart), Jankowski, S. (Stefan), Jarrett, M. (Mike), Jiang, J.-Y. (Ji-Yao), Johnson, F. (Faye), Jones, K.M. (Kelly M.), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kompanje, E.J.O. (Erwin), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Lanyon, L. (Linda), Laureys, S. (Steven), Lecky, F.E. (Fiona), Ledoux, D. (Didier), Lefering, R., Legrand, V. (Valerie), Lejeune, A. (Aurelie), Levi, L. (Leon), Lightfoot, R. (Roger), Lingsma, H.F. (Hester), Maas, A.I.R. (Andrew), Castaño-León, A.M. (Ana M), Maegele, M. (Marc), Majdan, M. (Marek), Manara, A. (Alex), Manley, G. (Geoffrey), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Melegh, B. (Béla), Menon, D.K. (David ), Menovsky, T. (Tomas), Mikolic, A. (Ana), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Nelson, D. (David), Newcombe, V.F. (Virginia F.), Nieboer, D. (Daan), Nyirádi, J. (József), Olubukola, O. (Otesile), Oresic, M. (Matej), Ortolano, F. (Fabrizio), Palotie, A. (Aarno), Parizel, P.M., Payen, J.-F. (Jean-François), Perera, N. (Natascha), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W.C. (Wilco), Piippo-Karjalainen, A. (Anna), Pirinen, M. (Matti), Ples, H. (Horia), Polinder, S. (Suzanne), Pomposo, I. (Inigo), Posti, J.P. (Jussi P), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rambadagalla, M. (Malinka), Rhodes, J.K.J. (Jonathan K.J.), Richardson, S. (Sylvia), Richter, S. (Sophie), Ripatti, S. (Samuli), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosand, J. (Jonathan), Rosenfeld, J.V. (Jeffrey V), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Rueckert, D. (Daniel), Rusnák, M. (Martin), Sahuquillo, J. (Juan), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Sandor, J. (Janos), Schäfer, N. (Nadine), Schmidt, S. (Silke), Schoechl, H. (Herbert), Schoonman, G.G. (Guus), Schou, R. (Rico), Schwendenwein, E. (Elisabeth), Sewalt, C. (Charlie), Skandsen, T. (Toril), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stanworth, S. (Simon), Stevens, R. (Robert), Stewart, W. (William), Steyerberg, E.W. (Ewout), Stocchetti, N. (Nino), Sundström, N. (Nina), Synnot, A. (Anneliese), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Taylor, M.S. (Mark Steven), Ao, B.T. (Braden Te), Tenovuo, O. (Olli), Theadom, A. (Alice), Thomas, M. (Matt), Tibboel, D. (Dick), Timmers, M. (Marjolein), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Maria Tudora, C. (Cristina), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Jagt, M. (Mathieu), Steen, G. (Gregory), Naalt, J. (Joukje), Jeroen, T.J.M.D. (T.J.M. van Dijck), Essen, T.A. (Thomas A.), Hecke, W. (Wim), Heugten, C. (Caroline), Praag, D. (Dominique), Vyvere, T. (Thijs), RoelWijk, P.J. (P. J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Velt, K. (Kimberley), Verheyden, J. (Jan), Vespa, P.M. (Paul M), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Steinbüchel, N. (Nicole), Voormolen, D. (Daphne), Vulekovic, P. (Peter), Wang, K.K.W. (Kevin), Wiegers, E. (Eveline), Williams, G. (Guy), Wilson, L. (Lindsay), Winzeck, S. (Stefan), Wolf, S. (Stefan), Yang, Z. (Zhihui), Ylén, P. (Peter), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Zelinkova, V. (Veronika), Ziverte, A. (Agate), and Zoerle, T. (Tommaso)
Abstract: Background: Fatigue is one of the most commonly reported subjective symptoms following traumatic brain injury (TBI). The aims were to assess frequency of fatigue over the first 6 months after TBI, and examine whether fatigue changes could be predicted by demographic characteristics, injury severity and comorbidities. Methods: Patients with acute TBI admitted to 65 trauma centers were enrolled in the study Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI). Subje
Published: 2020
Full Text: View/download PDF

59. Between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage in the subarachnoid hemorrhage international trialists (SAHIT) repository

Author: Dijkland, S.A. (Simone), Jaja, B.N.R. (Blessing), Jagt, M. (Mathieu) van der, Roozenbeek, B. (Bob), Vergouwen, M.D.I. (Mervyn D.I.), Suarez, J.I. (Jose I.), Torner, J.C. (James C.), Todd, M.M. (Michael M.), Van Den Bergh, H. (Huub), Saposnik, G. (Gustavo), Zumofen, D.W. (Daniel W.), Cusimano, M.D. (Michael D.), Mayer, S. (Stephan), Lo, B. (Benjamin), Steyerberg, E.W. (Ewout), Dippel, D.W.J. (Diederik), Schweizer, T.A. (Tom), Loch Macdonald, R. (R.), Lingsma, H.F. (Hester), Dijkland, S.A. (Simone), Jaja, B.N.R. (Blessing), Jagt, M. (Mathieu) van der, Roozenbeek, B. (Bob), Vergouwen, M.D.I. (Mervyn D.I.), Suarez, J.I. (Jose I.), Torner, J.C. (James C.), Todd, M.M. (Michael M.), Van Den Bergh, H. (Huub), Saposnik, G. (Gustavo), Zumofen, D.W. (Daniel W.), Cusimano, M.D. (Michael D.), Mayer, S. (Stephan), Lo, B. (Benjamin), Steyerberg, E.W. (Ewout), Dippel, D.W.J. (Diederik), Schweizer, T.A. (Tom), Loch Macdonald, R. (R.), and Lingsma, H.F. (Hester)
Abstract: OBJECTIVE Differences in clinical outcomes between centers and countries may reflect variation in patient characteristics, diagnostic and therapeutic policies, or quality of care. The purpose of this study was to investigate the presence and magnitude of between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage (aSAH). METHODS The authors analyzed data from 5972 aSAH patients enrolled in randomized clinical trials of 3 different treatments from the Subarachnoid Hemorrhage International Trialists (SAHIT) repository, including data from 179 centers and 20 countries. They used random effects logistic regression adjusted for patient characteristics and timing of aneurysm treatment to estimate between
Published: 2020
Full Text: View/download PDF

60. Pharmacogenomic response of low dose haloperidol in critically ill adults with delirium

Author: Trogrlić, Z. (Zoran), Jagt, M. (Mathieu) van der, Osse, R.J. (Robert Jan), Devlin, J.W. (John W.), Nieboer, D. (Daan), Koch, B.C.P. (Birgit), Schaik, R.H.N. (Ron) van, Hunfeld, N.G.M. (Nicole), Trogrlić, Z. (Zoran), Jagt, M. (Mathieu) van der, Osse, R.J. (Robert Jan), Devlin, J.W. (John W.), Nieboer, D. (Daan), Koch, B.C.P. (Birgit), Schaik, R.H.N. (Ron) van, and Hunfeld, N.G.M. (Nicole)
Abstract: Purpose: To characterize the pharmacogenomic response of low-dose haloperidol for delirium treatment in critically ill adults. Materials and methods: Single-center, pilot study of a convenience sample of ICU adults with delirium treated with low-dose IV haloperidol. Patients were evaluated for delirium with the ICDSC every 8 h. Serum haloperidol concentrations were collected on ICU days 2–6, CYP2D6 and CYP3A4 genotypes were characterized and patients were categorized as extensive (EM), intermediate (IM) or poor metabolizers (PM). Results: The 22 patients (median age 67 [IQR 48,77] years; median APACHE III 81[IQR 54,181]; CYP2D6 [EM = 12, IM = 7, PM = 3], CYP3A [EM = 18, IM = 4]) received a median [IQR] daily haloperidol dose of 3.0 [2.4, 4.5] mg. After adjusting for age, SOFA, and ICU day, neither an association between CYP2D6 (IM p = .67/PM p = .25) or CYP3A4 (IM p = .44) metabolizer status and serum haloperidol concentrations was found. After adjusting for age, SOFA, and ICU day, neither an association between daily haloperidol dose (p = .77) or ICDSC score (p = .13) and serum haloperidol concentrations was found. No patient experienced QTc interval prolongation (≥500 ms). Conclusions: This pilot study, the first to evaluate the pharmacogenomic response of low-dose haloperidol when used to treat delirium in the ICU, suggests CYP2D6/CYP3A4 metabolizer status does not affect the serum haloperidol concentrations.
Published: 2020
Full Text: View/download PDF

61. Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands

Author: Smit, L., Trogrlić, Z. (Zoran), Devlin, J.W., Osse, R.J. (Robert Jan), Ponssen, H.H., Slooter, A.J.C., Hunfeld, N.G.M., Rietdijk, W.J.R., Gommers, D.A.M.P.J. (Diederik), Jagt, M. (Mathieu) van der, Boogaard, M.W. (Merel), Brouwers, A. (Anke), Lens, J.A., van der Meer, B.J.M., Ponssen, H., Schoonderbeek, F.J., Simons, K.S., Berger, E., Bouman, A., Del Campo, M, van Duijn, D., Embden-van Donk, H., de Graaf, D., Hoogendoorn, E., Ormskerk, P., Roovers, N., Toscano, E., Vileito, A., van Zuylen, T., Exler, C., Berg, E. (Esther) van den, van Meeteren, J., Koopmanschap, M.A. (Marc), Smit, L., Trogrlić, Z. (Zoran), Devlin, J.W., Osse, R.J. (Robert Jan), Ponssen, H.H., Slooter, A.J.C., Hunfeld, N.G.M., Rietdijk, W.J.R., Gommers, D.A.M.P.J. (Diederik), Jagt, M. (Mathieu) van der, Boogaard, M.W. (Merel), Brouwers, A. (Anke), Lens, J.A., van der Meer, B.J.M., Ponssen, H., Schoonderbeek, F.J., Simons, K.S., Berger, E., Bouman, A., Del Campo, M, van Duijn, D., Embden-van Donk, H., de Graaf, D., Hoogendoorn, E., Ormskerk, P., Roovers, N., Toscano, E., Vileito, A., van Zuylen, T., Exler, C., Berg, E. (Esther) van den, van Meeteren, J., and Koopmanschap, M.A. (Marc)
Abstract: Introduction Delirium in critically ill adults is associated with prolonged hospital stay, increased mortality and greater cognitive and functional decline. Current practice guideline recommendations advocate the use of nonpharmacological strategies to reduce delirium. The routine use of scheduled haloperidol to treat delirium is not recommended given a lack of evidence regarding its ability to resolve delirium nor improve relevant short-term and longer-term outcomes. This study aims to evaluate the efficacy and safety of haloperidol for the treatment of delirium in adult critically ill patients to reduce days spent with coma or delirium. Methods and analysis EuRIDICE is a prospective, multicentre, randomised, double-blind, placebo-controlled trial. Study population consists of adult intensive care unit (ICU) patients without acute neurological injury who have delirium based on a positive Intensive Care Delirium Screening Checklist (ICDSC) or Confusion Assessment Method for the ICU (CAM-ICU) assessment. Intervention is intravenous haloperidol 2.5mg (or matching placebo) every 8 hours, titrated daily based on ICDSC or CAMICU positivity to a maximum of 5mg every 8 hours, until delirium resolution or ICU discharge. Main study endpoint is delirium and coma-free days (DCFD) up to 14 days after randomisation. Secondary endpoints include (1) 28-day and 1-year mortality, (2) cognitive and functional performance at 3 and 12 months, (3) patient and family delirium and ICU experience, (4) psychological sequelae during and after ICU stay, (4) safety concerns associated with haloperidol use and (5) cost-effectiveness. Differences in DCFDs between haloperidol and placebo group will be analysed using Poisson regression analysis. Study recruitment started in February 2018 and continues. Ethics and dissemination The study has been approved by the Medical Ethics Committee of the Erasmus University Medical Centre Rotterdam (MEC2017-511) and by the Institutional Review Boards of the pa
Published: 2020
Full Text: View/download PDF

62. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

Author: Russell, L.L. (Lucy L.), Greaves, C.V. (Caroline V.), Bocchetta, M. (Martina), Nicholas, J.M. (Jennifer), Convery, R.S. (Rhian S.), Moore, K. (Katrina), Cash, D.M. (David M.), Swieten, J.C. (John) van, Jiskoot, L.C. (Lize), Moreno, F. (Fermin), Sánchez-Valle, R. (Raquel), Borroni, B. (Barbara), Laforce, R. (Robert), Masellis, M. (Mario), Tartaglia, M.C. (Maria Carmela), Graff, C. (Caroline), Rotondo, E. (Emanuela), Galimberti, D. (Daniela), Rowe, J.B. (James), Finger, E. (Elizabeth), Synofzik, M. (Matthis), Vandenberghe, R. (Rik), De Mendonça, A. (Alexandre), Tagliavini, F. (Fabrizio), Santana, I. (Isabel), Ducharme, S. (Simon), Butler, C. (Chris), Gerhard, A. (Alex), Levin, J. (Johannes), Danek, A. (Adrian), Otto, M. (Markus), Warren, J.D. (Jason), Rohrer, J.D. (Jonathan), Rossor, M. (Martin), Fox, N.C. (Nick), Woollacott, I.O.C. (Ione O.C.), Shafei, R. (Rachelle), Heller, C. (Carolin), Guerreiro, R. (Rita), Bras, J. (Jose), Thomas, D.L. (David L), Mead, S. (Simon), Meeter, L.H.H. (Lieke), Panman, J.L. (Jessica), Papma, J.M. (Janne), Poos, J.M. (Jackie), Thornton, A.S. (Andrew), Pijnenburg, Y. (Yolanda), Barandiaran, M. (Myriam), Indakoetxea, B. (Begoña), Gabilondo, A. (Alazne), Tainta, M. (Mikel), de Arriba, M. (Maria), Gorostidi, A. (Ana), Zulaica, M. (Miren), Villanua, J. (Jorge), Diaz, Z. (Zigor), Borrego-Ecija, S. (Sergi), Olives, J. (Jaume), Lladó, A. (Albert), Balasa, M. (Mircea), Antonell, A. (Anna), Bargallo, N. (Nuria), Premi, E. (Enrico), Cosseddu MPsych, M. (Maura), Gazzina, S. (Stefano), Padovani, A. (Alessandro), Gasparotti, R. (Roberto), Archetti, S. (Silvana), Black, S.E. (Sandra), Mitchell, S. (Sara), Rogaeva, E. (Ekaterina), Freedman, M. (Morris), Keren, R. (Ron), Tang-Wai, D. (Daid), Öijerstedt, L. (Linn), Andersson, C. (Christin), Jelic, S. (Svetislav Svetislav), Thonberg, H. (Håkan), Arighi, A. (Andrea), Fenoglio, C. (Chiara), Scarpini, E. (Elio), Fumagalli, G. (Giorgio), Cope, T. (Thomas), Timberlake, C. (Carolyn), Rittman, T. (Timothy), Shoesmith, C. (Christen), Bartha, R. (Robart), Rademakers, S. (Suzanne), Wilke, C. (Carlo), Karnarth, H.-O. (Hans-Otto), Bender, B. (Benjamin), Bruffaerts, R. (Rose), Vandamme, P. (Philip), Vandenbulcke, M. (Mathieu), Ferreira, C.B. (Catarina B.), Miltenberger, G. (Gabriel), Maruta MPsych, C. (Carolina), Verdelho, A. (Ana), Afonso, S. (Sónia), Taipa, R. (Ricardo), Caroppo, P. (Paola), Di Fede, G. (Giuseppe), Giaccone, G. (Giuseppe), Muscio, C. (Cristina), Prioni, S. (Sara), Redaelli, V. (Veronica), Rossi, G. (Giacomina), Tiraboschi, P. (Pietro), Duro NPsych, D. (Diana), Almeida, M.R. (Maria R.), Castelo-Branco, M. (Miguel), Leitão, M.J. (Maria J.), Tabuas-Pereira, M. (Miguel), Santiago, B. (Beatriz), Gauthier, S. (Serge), Rosa-Neto, P. (Pedro), Veldsman, M. (Michele), Thompson, P.M. (Paul), Langheinrich, T. (Tobias), Prix, C. (Catharina), Hoegen, T. (Tobias), Wlasich, E. (Elisabeth), Loosli, S. (Sandra), Schonecker, S. (Sonja), Semler, E. (Elisa), Anderl-Straub, S. (Sarah), Russell, L.L. (Lucy L.), Greaves, C.V. (Caroline V.), Bocchetta, M. (Martina), Nicholas, J.M. (Jennifer), Convery, R.S. (Rhian S.), Moore, K. (Katrina), Cash, D.M. (David M.), Swieten, J.C. (John) van, Jiskoot, L.C. (Lize), Moreno, F. (Fermin), Sánchez-Valle, R. (Raquel), Borroni, B. (Barbara), Laforce, R. (Robert), Masellis, M. (Mario), Tartaglia, M.C. (Maria Carmela), Graff, C. (Caroline), Rotondo, E. (Emanuela), Galimberti, D. (Daniela), Rowe, J.B. (James), Finger, E. (Elizabeth), Synofzik, M. (Matthis), Vandenberghe, R. (Rik), De Mendonça, A. (Alexandre), Tagliavini, F. (Fabrizio), Santana, I. (Isabel), Ducharme, S. (Simon), Butler, C. (Chris), Gerhard, A. (Alex), Levin, J. (Johannes), Danek, A. (Adrian), Otto, M. (Markus), Warren, J.D. (Jason), Rohrer, J.D. (Jonathan), Rossor, M. (Martin), Fox, N.C. (Nick), Woollacott, I.O.C. (Ione O.C.), Shafei, R. (Rachelle), Heller, C. (Carolin), Guerreiro, R. (Rita), Bras, J. (Jose), Thomas, D.L. (David L), Mead, S. (Simon), Meeter, L.H.H. (Lieke), Panman, J.L. (Jessica), Papma, J.M. (Janne), Poos, J.M. (Jackie), Thornton, A.S. (Andrew), Pijnenburg, Y. (Yolanda), Barandiaran, M. (Myriam), Indakoetxea, B. (Begoña), Gabilondo, A. (Alazne), Tainta, M. (Mikel), de Arriba, M. (Maria), Gorostidi, A. (Ana), Zulaica, M. (Miren), Villanua, J. (Jorge), Diaz, Z. (Zigor), Borrego-Ecija, S. (Sergi), Olives, J. (Jaume), Lladó, A. (Albert), Balasa, M. (Mircea), Antonell, A. (Anna), Bargallo, N. (Nuria), Premi, E. (Enrico), Cosseddu MPsych, M. (Maura), Gazzina, S. (Stefano), Padovani, A. (Alessandro), Gasparotti, R. (Roberto), Archetti, S. (Silvana), Black, S.E. (Sandra), Mitchell, S. (Sara), Rogaeva, E. (Ekaterina), Freedman, M. (Morris), Keren, R. (Ron), Tang-Wai, D. (Daid), Öijerstedt, L. (Linn), Andersson, C. (Christin), Jelic, S. (Svetislav Svetislav), Thonberg, H. (Håkan), Arighi, A. (Andrea), Fenoglio, C. (Chiara), Scarpini, E. (Elio), Fumagalli, G. (Giorgio), Cope, T. (Thomas), Timberlake, C. (Carolyn), Rittman, T. (Timothy), Shoesmith, C. (Christen), Bartha, R. (Robart), Rademakers, S. (Suzanne), Wilke, C. (Carlo), Karnarth, H.-O. (Hans-Otto), Bender, B. (Benjamin), Bruffaerts, R. (Rose), Vandamme, P. (Philip), Vandenbulcke, M. (Mathieu), Ferreira, C.B. (Catarina B.), Miltenberger, G. (Gabriel), Maruta MPsych, C. (Carolina), Verdelho, A. (Ana), Afonso, S. (Sónia), Taipa, R. (Ricardo), Caroppo, P. (Paola), Di Fede, G. (Giuseppe), Giaccone, G. (Giuseppe), Muscio, C. (Cristina), Prioni, S. (Sara), Redaelli, V. (Veronica), Rossi, G. (Giacomina), Tiraboschi, P. (Pietro), Duro NPsych, D. (Diana), Almeida, M.R. (Maria R.), Castelo-Branco, M. (Miguel), Leitão, M.J. (Maria J.), Tabuas-Pereira, M. (Miguel), Santiago, B. (Beatriz), Gauthier, S. (Serge), Rosa-Neto, P. (Pedro), Veldsman, M. (Michele), Thompson, P.M. (Paul), Langheinrich, T. (Tobias), Prix, C. (Catharina), Hoegen, T. (Tobias), Wlasich, E. (Elisabeth), Loosli, S. (Sandra), Schonecker, S. (Sonja), Semler, E. (Elisa), and Anderl-Straub, S. (Sarah)
Abstract: A key symptom of frontotemporal dementia (FTD) is difficulty interacting socially with others. Social cognition problems in FTD include impaired emotion processing and theory of mind difficulties, and whilst these have been studied extensively in sporadic FTD, few studies have investigated them in familial FTD. Facial Emotion Recognition (FER) and Faux Pas (FP) recognition tests were used to study social cognition within the Genetic Frontotemporal Dementia Initiative (GENFI), a large familial FTD cohort of C9orf72, GRN, and MAPT mutation carriers. 627 participants undertook at least one of the tasks, and were separated into mutation-negative healthy controls, presymptomatic mutation carriers (split into early and late groups) and symptomatic mutation carriers. Groups were compared using a linear regression model with bootstrapping, adjusting for age, sex, education, and for the FP recognition test, language. Neural correlates of social cognition deficits were explored using a voxel-based morphometry (VBM) study. All three of the symptomatic genetic groups were impaired on both tasks with no significant difference between them. However, prior to onset, only the late presymptomatic C9orf72 mutation carriers on the FER test were impaired compared to the control group, with a subanalysis showing differences particularly in fear and sadness. The VBM analysis revealed that impaired social cognition was mainly associated with a left hemisphere predominant network of regions involving particularly the striatum, orbitofrontal cortex and insula, and to a lesser extent the inferomedial temporal lobe and other areas of the frontal lobe. In conclusion, theory of mind and emotion processing abilities are impaired in familial FTD, with early changes occurring prior to symptom onset in C9orf72 presymptomatic mutation carriers. Future work should investigate how performance changes over time, in order to gain a clearer insight into social cognitive impairment over the course of the
Published: 2020
Full Text: View/download PDF

63. Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis

Author: Jouneau, S. (Stéphane), Crestani, B. (Bruno), Thibault, R. (Ronan), Lederlin, M. (Mathieu), Vernhet, L. (Laurent), Valenzuela, C. (Claudia), Wijsenbeek-Lourens, M.S. (Marlies), Kreuter, M. (Michael), Stansen, W. (Wibke), Quaresma, M. (Manuel), Cottin, V. (Vincent), Jouneau, S. (Stéphane), Crestani, B. (Bruno), Thibault, R. (Ronan), Lederlin, M. (Mathieu), Vernhet, L. (Laurent), Valenzuela, C. (Claudia), Wijsenbeek-Lourens, M.S. (Marlies), Kreuter, M. (Michael), Stansen, W. (Wibke), Quaresma, M. (Manuel), and Cottin, V. (Vincent)
Abstract: Background: Nintedanib is an approved therapy for idiopathic pulmonary fibrosis (IPF). Some patients treated with nintedanib experience weight loss. Exploratory data suggest that low body mass index or weight loss are associated with worse outcomes in patients with IPF. We investigated whether BMI at baseline or weight loss over 52 weeks was associated with FVC decline, or influenced the effect of nintedanib, in patients with IPF. Methods: Using pooled data from the two INPULSIS trials, we analysed the rate of decline in FVC (mL/yr) over 52 weeks in patients treated with nintedanib and placebo in subgroups by baseline BMI (< 25; ≥25 to < 30; ≥30 kg/m2) and by weight loss over 52 weeks (≤5; > 5%) using random coefficient regression. Results: In the placebo group, the mean rate of FVC decline over 52 weeks was numerically greater in patients with lower baseline BMI (− 283.3 [SE 22.4], − 207.9 [20.9] and − 104.5 [21.4] in patients with BMI < 25 kg/m2, ≥25 to < 30 kg/m2 and ≥ 30 kg/m2, respectively). Nintedanib reduced the rate of FVC decline versus placebo in all subgroups by BMI, with a consistent treatment effect across subgroups (interaction p = 0.31). In the placebo group, the mean rate of FVC decline was numerically greater in patients with > 5% than ≤5% weight loss over 52 weeks (− 312.7 [SE 32.2] versus − 199.5 [SE 14.4] mL/year). Nintedanib reduced the rate of FVC decline versus placebo in both subgroups by weight loss, with a greater treatment effect in patients with > 5% weight loss (interaction p = 0.0008). The adverse event profile of nintedanib was similar across subgroups. Conclusions: In patients with IPF, lower BMI and weight loss may be associated with faster decline in FVC. Nintedanib reduces the rate of FVC decline both in patients who lose weight on treatment and those who do not. Trial registration: ClinicalTrials.gov; Nos. NCT01335464 and NCT01335477; URL: www.clinicaltrials.gov.
Published: 2020
Full Text: View/download PDF

64. Prospective multicentre multifaceted before-after implementation study of ICU delirium guidelines: a process evaluation

Author: Trogrlić, Z. (Zoran), Jagt, M. (Mathieu) van der, Achterberg, T. (Theo) van, Ponssen, H., Schoonderbeek, J., Schreiner, F. (Frodo), Verbrugge, S., Dijkstra, A., Bakker, J., Ista, E. (Erwin), Trogrlić, Z. (Zoran), Jagt, M. (Mathieu) van der, Achterberg, T. (Theo) van, Ponssen, H., Schoonderbeek, J., Schreiner, F. (Frodo), Verbrugge, S., Dijkstra, A., Bakker, J., and Ista, E. (Erwin)
Abstract: Objective We aimed to explore: the exposure of healthcare workers to a delirium guidelines implementation programme; effects on guideline adherence at intensive care unit (ICU) level; impact on knowledge and barriers, and experiences with the implementation. Design A mixed-methods process evaluation of a prospective multicentre implementation study. Setting Six ICUs. Participants 4449 adult ICU patients and 500 ICU professionals approximately. Intervention A tailored implementation programme. Main outcome measure Adherence to delirium guidelines recommendations at ICU level before, during and after implementation; knowledge and perceived barriers; and experiences with the implementation. Results Five of six ICUs were exposed to all implementation strategies as planned. More than 85% followed the required e-learnings; 92% of the nurses attended the clinical classroom lessons; five ICUs used all available implementation strategies and perceived to have implemented all guideline recommendations (>90%). Adherence to predefined performance indicators (PIs) at ICU level was only above the preset target (>85%) for delirium screening. For all other PIs, the inter-ICU variability was between 34% and 72%. The implementation of delirium guidelines was feasible and successful in resolving the majority of barriers found before the implementation. The improvement was well sustained 6months after full guideline implementation. Knowledge about delirium was improved (from 61% to 65%). The implementation programme was experienced as very successful. Conclusions Multifaceted implementation can improve and sustain adherence to delirium guidelines, is feasible and can largely be performed as planned. However, variability in delirium guideline adherence at individual ICUs remains a challenge, indicating the need for more tailoring at centre level.
Published: 2020
Full Text: View/download PDF

65. Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy: A Pan-European Propensity Score Matched Study

Author: Klompmaker, S. (Sjors), van Hilst, J. (Jony), Wellner, U.F. (Ulrich F.), Busch, O.R.C. (Olivier), Coratti, A. (Andrea), D'Hondt, M. (Mathieu), Dokmak, S. (Safi), Festen, S. (Sebastiaan), Kerem, M. (Mustafa), Khatkov, I. (Igor), Lips, D.J., Lombardo, C. (Carlo), Luyer, M. (Misha), Manzoni, A. (Alberto), Molenaar, I.Q. (I. Quintus), Rosso, E. (Edoardo), Saint-Marc, O. (Olivier), Vansteenkiste, F. (Franky), Wittel, U.A. (Uwe A.), Bonsing, B.A. (Bert), Groot Koerkamp, B. (Bas), Abu Hilal, M., Fuks, D. (David), Poves, I. (Ignasi), Keck, T. (Tobias), Boggi, U. (Ugo), Besselink, M.G. (Marc), Klompmaker, S. (Sjors), van Hilst, J. (Jony), Wellner, U.F. (Ulrich F.), Busch, O.R.C. (Olivier), Coratti, A. (Andrea), D'Hondt, M. (Mathieu), Dokmak, S. (Safi), Festen, S. (Sebastiaan), Kerem, M. (Mustafa), Khatkov, I. (Igor), Lips, D.J., Lombardo, C. (Carlo), Luyer, M. (Misha), Manzoni, A. (Alberto), Molenaar, I.Q. (I. Quintus), Rosso, E. (Edoardo), Saint-Marc, O. (Olivier), Vansteenkiste, F. (Franky), Wittel, U.A. (Uwe A.), Bonsing, B.A. (Bert), Groot Koerkamp, B. (Bas), Abu Hilal, M., Fuks, D. (David), Poves, I. (Ignasi), Keck, T. (Tobias), Boggi, U. (Ugo), and Besselink, M.G. (Marc)
Abstract: OBJECTIVE: To assess short-term outcomes after minimally invasive (laparoscopic, robot-assisted, and hybrid) pancreatoduodenectomy (MIPD) versus open pancreatoduodenectomy (OPD) among European centers. BACKGROUND: Current evidence on MIPD is based on national registries or single expert centers. International, matched studies comparing outcomes for MIPD and OPD are lacking. METHODS: Retrospective propensity score matched study comparing MIPD in 14 centers (7 countries) performing ≥10 MIPDs annually (2012-2017) versus OPD in 53 German/Dutch surgical registry centers performing ≥10 OPDs annually (2014-2017). Primary outcome was 30-day major morbidity (Clavien-Dindo ≥3). RESULTS: Of 4220 patients, 729/730 MIPDs (412 laparoscopic, 184 robot-assisted, and 130 hybrid) were matched to 729 OPDs. Median annual case-volume was 19 MIPDs (interquartile range, IQR 13-22), including the first MIPDs performed in 10/14 centers, and 31 OPDs (IQR 21-38). Major morbidity (28% vs 30%, P = 0.526), mortality (4.0% vs 3.3%, P = 0.576), percutaneous drainage (12% vs 12%, P = 0.809), reoperation (11% vs 13%, P = 0.329), and hospital stay (mean 17 vs 17 days, P > 0.99) were comparable between MIPD and OPD. Grade-B/C postoperative pancreatic fistula (POPF) (23% vs 13%, P < 0.001) occurred more frequently after MIPD. Single-row pancreatojejunostomy was associated with POPF in MIPD (odds ratio, OR 2.95, P < 0.001), but not in OPD. Laparoscopic, robot-assisted, and hybrid MIPD had comparable major morbidity (27% vs 27% vs 35%), POPF (24% vs 19% vs 25%), and mortality (2.9% vs 5.2% vs 5.4%), with a fewer conversions in robot-assisted- versus laparoscopic MIPD (5% vs 26%, P < 0.001). CONCLUSIONS: In the early experience of 14 European centers performing ≥10 MIPDs annually, no differences were found in major morbidity, mortality, and hospital stay between MIPD and OPD. The high rates of POPF and conversion, and the lack of superior outcomes (ie, hospital stay, morbidity) could indicate that more ex
Published: 2020
Full Text: View/download PDF

66. Tracheal intubation in traumatic brain injury

Author: Gravesteijn, B.Y. (Benjamin), Sewalt, C.A. (Charlie), Nieboer, D. (Daan), Menon, D.K. (David Krishna), Maas, A.I.R. (Andrew), Lecky, F.E. (Fiona), Klimek, M. (Markus), Lingsma, H.F. (Hester), Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andelic, N. (Nada), Andreassen, L. (Lasse), Anke, A. (Audny), Antoni, A. (Anna), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Barzo, P. (P.), Beauvais, R. (Romuald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Belli, A. (Antonio), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Blaabjerg, M. (Morten), Bragge, P. (Peter), Brazinova, A. (Alexandra), Brinck, V. (Vibeke), Brooker, J. (Joanne), Brorsson, C. (Camilla), Buki, A. (Andras), Bullinger, M. (Monika), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Carbonara, M. (Marco), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Citerio, G. (Giuseppe), Ceyisakar, I.E. (Iris), Clusmann, H. (Hans), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Covic, A. (Amra), Curry, N. (Nicola), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), Dawes, H. (Helen), De Keyser, V. (Véronique), Degos, V. (Vincent), Della Corte, F. (Francesco), Boogert, H.D. (Hugo den), Depreitere, B. (Bart), Đilvesi, Đ. (Đula), Dixit, A. (Abhishek), Donoghue, E. (Emma), Dreier, J.P. (Jens), Dulière, G.-L. (Guy-Loup), Ercole, A. (Ari), Esser, P. (Patrick), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Feigin, V.L. (Valery L.), Foks, K.A. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Gagliardo, P. (Pablo), Galanaud, D. (Damien), Gantner, D. (Dashiell), Gao, G. (Guoyi), George, P. (Pradeep), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Glocker, B. (Ben), Golubovic, J. (Jagoš), Gomez, P.A. (Pedro A.), Gratz, J. (Johannes), Grossi, F. (Francesca), Gruen, R.L. (Russell), Gupta, D. (Deepak), Haagsma, J.A. (Juanita), Haitsma, I. (Iain), Helbok, R. (Raimund), Helseth, E. (Eirik), Horton, L. (Lindsay), Huijben, A.L.C.J.R.M. (Jilske), Hutchinson, P.J. (Peter J.), Jacobs, B.C. (Bart), Jankowski, S. (Stefan), Jarrett, M. (Mike), Jiang, J.-Y. (Ji-Yao), Johnson, F. (Faye), Jones, K.M. (Kelly M.), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kompanje, E.J.O. (Erwin), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Lanyon, L. (Linda), Laureys, S. (Steven), Ledoux, D. (Didier), Lefering, R., Legrand, V. (Valerie), Lejeune, A. (Aurelie), Levi, L. (Leon), Lightfoot, R. (Roger), Maas, A.I.R. (Andrew I.R.), Castaño-León, A.M. (Ana M.), Maegele, M. (Marc), Majdan, M. (Marek), Manara, A. (Alex), Manley, G. (Geoffrey), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Melegh, B. (Béla), Menon, D.K. (David ), Menovsky, T. (Tomas), Mikolic, A. (Ana), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Nelson, D. (David), Newcombe, V.F. (Virginia F.), Nyirádi, J. (József), Olubukola, O. (Otesile), Oresic, M. (Matej), Ortolano, F. (Fabrizio), Palotie, A. (Aarno), Parizel, P.M., Payen, J.-F. (Jean-François), Perera, N. (Natascha), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W.C. (Wilco), Piippo-Karjalainen, A. (Anna), Pirinen, M. (Matti), Ples, H. (Horia), Polinder, S. (Suzanne), Pomposo, I. (Inigo), Posti, J.P. (Jussi P.), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rambadagalla, M. (Malinka), Rhodes, J.K.J. (Jonathan K.J.), Richardson, S. (Sylvia), Richter, S. (Sophie), Ripatti, S. (Samuli), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosand, J. (Jonathan), Rosenfeld, J.V. (Jeffrey V.), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Rueckert, D. (Daniel), Rusnák, M. (Martin), Sahuquillo, J. (Juan), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Sandor, J. (Janos), Schäfer, N. (Nadine), Schmidt, S. (Silke), Schoechl, H. (Herbert), Schoonman, G.G. (Guus), Schou, R. (Rico), Schwendenwein, E. (Elisabeth), Skandsen, T. (Toril), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stanworth, S. (Simon), Stevens, R. (Robert), Stewart, W. (William), Steyerberg, E.W. (Ewout), Stocchetti, N. (Nino), Sundström, N. (Nina), Synnot, A. (Anneliese), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Taylor, M.S. (Mark Steven), Ao, B.T. (Braden Te), Tenovuo, O. (Olli), Theadom, A. (Alice), Thomas, M. (Matt), Tibboel, D. (Dick), Timmers, M. (Marjolein), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Tudora, C.M. (Cristina Maria), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Jagt, M. (Mathieu) van der, Van der Steen, G. (Gregory), Naalt, J. (Joukje) van der, van Dijck, J.T.J.M. (Jeroen T.J.M.), van Essen, T.A. (Thomas A.), Hecke, W. (Wim) van, van Heugten, C.M. (Caroline M.), Van Praag, D. (Dominique), Vyvere, T.V. (Thijs Vande), van Wijk, R.P.J. (Roel P.J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Velt, K.B. (Kimberley), Verheyden, J. (Jan), Vespa, P.M. (Paul M.), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Von Steinbüchel, N. (Nicole), Voormolen, D.C. (Daphne), Vulekovic, P. (Peter), Wang, K.K.W. (Kevin), Wiegers-Groeneweg, E.J.A. (Eveline), Williams, G. (Guy), Wilson, L. (Lindsay), Winzeck, S. (Stefan), Wolf, S. (Stefan), Yang, Z. (Zhihui), Ylén, P. (Peter), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Zelinkova, V. (Veronika), Ziverte, A. (Agate), Zoerle, T. (Tommaso), Gravesteijn, B.Y. (Benjamin), Sewalt, C.A. (Charlie), Nieboer, D. (Daan), Menon, D.K. (David Krishna), Maas, A.I.R. (Andrew), Lecky, F.E. (Fiona), Klimek, M. (Markus), Lingsma, H.F. (Hester), Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andelic, N. (Nada), Andreassen, L. (Lasse), Anke, A. (Audny), Antoni, A. (Anna), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Barzo, P. (P.), Beauvais, R. (Romuald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Belli, A. (Antonio), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Blaabjerg, M. (Morten), Bragge, P. (Peter), Brazinova, A. (Alexandra), Brinck, V. (Vibeke), Brooker, J. (Joanne), Brorsson, C. (Camilla), Buki, A. (Andras), Bullinger, M. (Monika), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Carbonara, M. (Marco), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Citerio, G. (Giuseppe), Ceyisakar, I.E. (Iris), Clusmann, H. (Hans), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Covic, A. (Amra), Curry, N. (Nicola), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), Dawes, H. (Helen), De Keyser, V. (Véronique), Degos, V. (Vincent), Della Corte, F. (Francesco), Boogert, H.D. (Hugo den), Depreitere, B. (Bart), Đilvesi, Đ. (Đula), Dixit, A. (Abhishek), Donoghue, E. (Emma), Dreier, J.P. (Jens), Dulière, G.-L. (Guy-Loup), Ercole, A. (Ari), Esser, P. (Patrick), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Feigin, V.L. (Valery L.), Foks, K.A. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Gagliardo, P. (Pablo), Galanaud, D. (Damien), Gantner, D. (Dashiell), Gao, G. (Guoyi), George, P. (Pradeep), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Glocker, B. (Ben), Golubovic, J. (Jagoš), Gomez, P.A. (Pedro A.), Gratz, J. (Johannes), Grossi, F. (Francesca), Gruen, R.L. (Russell), Gupta, D. (Deepak), Haagsma, J.A. (Juanita), Haitsma, I. (Iain), Helbok, R. (Raimund), Helseth, E. (Eirik), Horton, L. (Lindsay), Huijben, A.L.C.J.R.M. (Jilske), Hutchinson, P.J. (Peter J.), Jacobs, B.C. (Bart), Jankowski, S. (Stefan), Jarrett, M. (Mike), Jiang, J.-Y. (Ji-Yao), Johnson, F. (Faye), Jones, K.M. (Kelly M.), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kompanje, E.J.O. (Erwin), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Lanyon, L. (Linda), Laureys, S. (Steven), Ledoux, D. (Didier), Lefering, R., Legrand, V. (Valerie), Lejeune, A. (Aurelie), Levi, L. (Leon), Lightfoot, R. (Roger), Maas, A.I.R. (Andrew I.R.), Castaño-León, A.M. (Ana M.), Maegele, M. (Marc), Majdan, M. (Marek), Manara, A. (Alex), Manley, G. (Geoffrey), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Melegh, B. (Béla), Menon, D.K. (David ), Menovsky, T. (Tomas), Mikolic, A. (Ana), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Nelson, D. (David), Newcombe, V.F. (Virginia F.), Nyirádi, J. (József), Olubukola, O. (Otesile), Oresic, M. (Matej), Ortolano, F. (Fabrizio), Palotie, A. (Aarno), Parizel, P.M., Payen, J.-F. (Jean-François), Perera, N. (Natascha), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W.C. (Wilco), Piippo-Karjalainen, A. (Anna), Pirinen, M. (Matti), Ples, H. (Horia), Polinder, S. (Suzanne), Pomposo, I. (Inigo), Posti, J.P. (Jussi P.), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rambadagalla, M. (Malinka), Rhodes, J.K.J. (Jonathan K.J.), Richardson, S. (Sylvia), Richter, S. (Sophie), Ripatti, S. (Samuli), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosand, J. (Jonathan), Rosenfeld, J.V. (Jeffrey V.), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Rueckert, D. (Daniel), Rusnák, M. (Martin), Sahuquillo, J. (Juan), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Sandor, J. (Janos), Schäfer, N. (Nadine), Schmidt, S. (Silke), Schoechl, H. (Herbert), Schoonman, G.G. (Guus), Schou, R. (Rico), Schwendenwein, E. (Elisabeth), Skandsen, T. (Toril), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stanworth, S. (Simon), Stevens, R. (Robert), Stewart, W. (William), Steyerberg, E.W. (Ewout), Stocchetti, N. (Nino), Sundström, N. (Nina), Synnot, A. (Anneliese), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Taylor, M.S. (Mark Steven), Ao, B.T. (Braden Te), Tenovuo, O. (Olli), Theadom, A. (Alice), Thomas, M. (Matt), Tibboel, D. (Dick), Timmers, M. (Marjolein), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Tudora, C.M. (Cristina Maria), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Jagt, M. (Mathieu) van der, Van der Steen, G. (Gregory), Naalt, J. (Joukje) van der, van Dijck, J.T.J.M. (Jeroen T.J.M.), van Essen, T.A. (Thomas A.), Hecke, W. (Wim) van, van Heugten, C.M. (Caroline M.), Van Praag, D. (Dominique), Vyvere, T.V. (Thijs Vande), van Wijk, R.P.J. (Roel P.J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Velt, K.B. (Kimberley), Verheyden, J. (Jan), Vespa, P.M. (Paul M.), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Von Steinbüchel, N. (Nicole), Voormolen, D.C. (Daphne), Vulekovic, P. (Peter), Wang, K.K.W. (Kevin), Wiegers-Groeneweg, E.J.A. (Eveline), Williams, G. (Guy), Wilson, L. (Lindsay), Winzeck, S. (Stefan), Wolf, S. (Stefan), Yang, Z. (Zhihui), Ylén, P. (Peter), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Zelinkova, V. (Veronika), Ziverte, A. (Agate), and Zoerle, T. (Tommaso)
Abstract: Background: We aimed to study the associations between pre- and in-hospital tracheal intubation and outcomes in traumatic brain injury (TBI), and whether the association varied according to injury severity. Methods: Data from the international prospective pan-European cohort study, Collaborative European NeuroTrauma Effectiveness Research for TBI (CENTER-TBI), were used (n=4509). For prehospital intubation, we excluded self-presenters. For in-hospital intubation, patients whose tracheas were intubated on-scene were excluded. The association between intubation and outcome was analysed with ordinal regression with adjustment for the International Mission for Prognosis and Analysis of Clinical Trials in TBI variables and extracranial injury. We assessed whether the effect of intubation varied by injury severity by testing the added value of an interaction term with likelihood ratio tests. Results: In the prehospital analysis, 890/3736 (24%) patients had their tracheas intubated at scene. In the in-hospital analysis, 460/2930 (16%) patients had their tracheas intubated in the emergency department. There was no adjusted overall effect on functional outcome of prehospital intubation (odds ratio=1.01; 95% confidence interval, 0.79–1.28; P=0.96), and the adjusted overall effect of in-hospital intubation was not significant (odds ratio=0.86; 95% confidence interval, 0.65–1.13; P=0.28). However, prehospital intubation was associated with better functional outcome in patients with higher thorax and abdominal Abbreviated Injury Scale scores (P=0.009 and P=0.02, respectively), whereas in-hospital intubation was associated with better outcome in patients with lower Glasgow Coma Scale scores (P=0.01): in-hospital intubation was associated with better functional outcome in patients with Glasgow Coma Scale scores of 10 or lower. Conclusion: The benefits and harms of tracheal intubation should be carefully evaluated in patients with TBI to optimise benefit. This study suggests that e
Published: 2020
Full Text: View/download PDF

67. Fulminant cerebral edema as a lethal manifestation of COVID-19

Author: van den Enden, A.J.M. (Antoon J.M.), Gils, L. (Lennart) van, Labout, J.A.M. (Joost), Jagt, M. (Mathieu) van der, Moudrous, W. (Walid), van den Enden, A.J.M. (Antoon J.M.), Gils, L. (Lennart) van, Labout, J.A.M. (Joost), Jagt, M. (Mathieu) van der, and Moudrous, W. (Walid)
Abstract: The contribution of neurological symptomatology to morbidity and mortality after infection with Severe Acute Respiratory Syndrome-associated Coronavirus (SARS CoV II) is ill-defined. We hereby present a case of a 57-year old male patient, in excellent physical condition, who was admitted to the Intensive Care Unit (ICU), with respiratory distress duo to SARS CoV
Published: 2020
Full Text: View/download PDF

68. The LifeCycle Project-EU Child Cohort Network: a federated analysis infrastructure and harmonized data of more than 250,000 children and parents

Author: Jaddoe, V.W.V. (Vincent), Felix, J.F. (Janine), Andersen, A-M.N. (Anne-Marie Nybo), Charles, M.A., Chatzi, L. (Leda), Corpeleijn, E. (Eva), Donner, N. (Nina), Elhakeem, A. (Ahmed), Hagen, K. (Knut), Foong, R. (Rachel), Grote, V. (Veit), Haakma, S. (Sido), Hanson, M. (Mark), Harris, J.R. (Jennifer), Heude, B. (Barbara), Huang, R.-C. (Rae-Chi), Inskip, H.M. (Hazel), Järvelin, M.-R. (Marjo-Riitta), Koletzko, B. (Berthold), Lawlor, D.A. (Debbie), Lindeboom, M. (Maarten), McEachan, R.R.C. (Rosemary R. C.), Mikkola, T.M. (Tuija M.), Nader, J.L.T. (Johanna L. T.), de Moira, A.P. (Angela Pinot), Pizzi, C. (Costanza), Richiardi, L. (Lorenzo), Sebert, S. (Sylvain), Schwalber, A. (Ameli), Sunyer, J. (Jordi), Swertz, M.A. (Morris A.), Vafeiadi, M. (Marina), Vrijheid, M. (Martine), Wright, J. (John), Duijts, L. (Liesbeth), El Marroun, H. (Hanan), Gaillard, R. (Romy), Santos, S. (Susana), Geurtsen, M.L. (Madelon L.), Kooijman, M.N. (Marjolein), Mensink-Bout, S.M. (Sara M.), Vehmeijer, F.O.L. (Florianne O.L.), Voerman, E. (Ellis), Nieuwenhuijsen, M. (Mark), Basagaña, X. (Xavier), Bustamante, M. (Mariona), Casas, M. (Miguel), de Castro, M. (Montserrat), Cirugeda, L.E. (Lourdes E.), Fernández-Barrés, S., Fossati, S. (Serena), Garcia, R. (Raquel), Julvez, J. (Jordi), Lertxundi, A. (Aitana), Lertxundi, N. (Nerea), Llop, S. (Sabrina), López-Vicente, M. (Mònica), Lopez-Espinosa, M.-J. (Maria-Jose), Maitre, L. (Lea), Murcia, M. (Mario), Lea, J. (Jose), Urquiza, H. (H.), Warembourg, C. (Charline), Zugna, D. (Daniela), Popovic, M. (Maja), Isaevska, E. (Elena), Maule, M. (Milena), Moccia, C. (Chiara), Moirano, G. (Giovenale), Rasella, D. (Davide), Hanson, M.A. (Mark A.), Inskip, H.M. (Hazel M.), Jacob, C.M. (Chandni Maria), Salika, T. (Theodosia), Cadman, T. (Tim), Strandberg-Larsen, K.M. (Katrine M.), Pedersen, M. (Marie), Vinther, J.L. (Johan L.), Wilson, P. (Paul), Mason, D. (Dan), Yang, T.C. (Tiffany C.), Cardol, M. (Marloes), van Enckevoort, E. (Esther), Hyde, E. (Eleanor), Scholtens, S. (Salome), Snieder, H. (Harold), Thio, C.H.L. (Chris H. L.), Chatzi, L. (Lida), Margetaki, K.C.A. (Katerina C. A.), Roumeliotaki, T. (Theano), Nader, J.L. (Johanna L.), Knudsen, G.P. (Gun Peggy), Magnus, P. (Per), Panico, L. (Lidia), Ichou, M. (Mathieu), de Lauzon-Guillain, B. (Blandine), Dargent-Molina, P. (Patricia), Cornet, M. (Maxime), Florian, S.M. (Sandra M.), Harrar, F. (Faryal), Lepeule, J. (Johanna), Lioret, S., Melchior, M. (Maria), Plancoulaine, S. (Sabine), Männikkö, M. (Minna), Parmar, P. (Priyanka), Rautio, N. (Nina), Ronkainen, J. (Justiina), Tolvanen, M. (Mimmi), Aumüller, N. (Nicole), Closa-Monasterolo, R. (Ricardo), Escribano, J. (Joaquin), Ferré, N. (Natalia), Gruszfeld, D. (Dariusz), Gürlich, K. (Kathrin), Langhendries, J.P. (Jean Paul), Luque, V. (Verónica), Riva, E. (Enrica), Schwarzfischer, P. (Phillipp), Totzauer, M. (Martina), Verduci, E. (Elvira), Xhonneux, A. (Annick), Zaragoza-Jordana, M. (Marta), Schwalber, A. (Amelie), Foong, R.E. (Rachel E.), Hall, G.L. (Graham L.), Lin, A. (Ashleigh), Carson, J. (Jennie), Melton, P. (Phillip), Rauschert, S. (Sebastian), Jaddoe, V.W.V. (Vincent), Felix, J.F. (Janine), Andersen, A-M.N. (Anne-Marie Nybo), Charles, M.A., Chatzi, L. (Leda), Corpeleijn, E. (Eva), Donner, N. (Nina), Elhakeem, A. (Ahmed), Hagen, K. (Knut), Foong, R. (Rachel), Grote, V. (Veit), Haakma, S. (Sido), Hanson, M. (Mark), Harris, J.R. (Jennifer), Heude, B. (Barbara), Huang, R.-C. (Rae-Chi), Inskip, H.M. (Hazel), Järvelin, M.-R. (Marjo-Riitta), Koletzko, B. (Berthold), Lawlor, D.A. (Debbie), Lindeboom, M. (Maarten), McEachan, R.R.C. (Rosemary R. C.), Mikkola, T.M. (Tuija M.), Nader, J.L.T. (Johanna L. T.), de Moira, A.P. (Angela Pinot), Pizzi, C. (Costanza), Richiardi, L. (Lorenzo), Sebert, S. (Sylvain), Schwalber, A. (Ameli), Sunyer, J. (Jordi), Swertz, M.A. (Morris A.), Vafeiadi, M. (Marina), Vrijheid, M. (Martine), Wright, J. (John), Duijts, L. (Liesbeth), El Marroun, H. (Hanan), Gaillard, R. (Romy), Santos, S. (Susana), Geurtsen, M.L. (Madelon L.), Kooijman, M.N. (Marjolein), Mensink-Bout, S.M. (Sara M.), Vehmeijer, F.O.L. (Florianne O.L.), Voerman, E. (Ellis), Nieuwenhuijsen, M. (Mark), Basagaña, X. (Xavier), Bustamante, M. (Mariona), Casas, M. (Miguel), de Castro, M. (Montserrat), Cirugeda, L.E. (Lourdes E.), Fernández-Barrés, S., Fossati, S. (Serena), Garcia, R. (Raquel), Julvez, J. (Jordi), Lertxundi, A. (Aitana), Lertxundi, N. (Nerea), Llop, S. (Sabrina), López-Vicente, M. (Mònica), Lopez-Espinosa, M.-J. (Maria-Jose), Maitre, L. (Lea), Murcia, M. (Mario), Lea, J. (Jose), Urquiza, H. (H.), Warembourg, C. (Charline), Zugna, D. (Daniela), Popovic, M. (Maja), Isaevska, E. (Elena), Maule, M. (Milena), Moccia, C. (Chiara), Moirano, G. (Giovenale), Rasella, D. (Davide), Hanson, M.A. (Mark A.), Inskip, H.M. (Hazel M.), Jacob, C.M. (Chandni Maria), Salika, T. (Theodosia), Cadman, T. (Tim), Strandberg-Larsen, K.M. (Katrine M.), Pedersen, M. (Marie), Vinther, J.L. (Johan L.), Wilson, P. (Paul), Mason, D. (Dan), Yang, T.C. (Tiffany C.), Cardol, M. (Marloes), van Enckevoort, E. (Esther), Hyde, E. (Eleanor), Scholtens, S. (Salome), Snieder, H. (Harold), Thio, C.H.L. (Chris H. L.), Chatzi, L. (Lida), Margetaki, K.C.A. (Katerina C. A.), Roumeliotaki, T. (Theano), Nader, J.L. (Johanna L.), Knudsen, G.P. (Gun Peggy), Magnus, P. (Per), Panico, L. (Lidia), Ichou, M. (Mathieu), de Lauzon-Guillain, B. (Blandine), Dargent-Molina, P. (Patricia), Cornet, M. (Maxime), Florian, S.M. (Sandra M.), Harrar, F. (Faryal), Lepeule, J. (Johanna), Lioret, S., Melchior, M. (Maria), Plancoulaine, S. (Sabine), Männikkö, M. (Minna), Parmar, P. (Priyanka), Rautio, N. (Nina), Ronkainen, J. (Justiina), Tolvanen, M. (Mimmi), Aumüller, N. (Nicole), Closa-Monasterolo, R. (Ricardo), Escribano, J. (Joaquin), Ferré, N. (Natalia), Gruszfeld, D. (Dariusz), Gürlich, K. (Kathrin), Langhendries, J.P. (Jean Paul), Luque, V. (Verónica), Riva, E. (Enrica), Schwarzfischer, P. (Phillipp), Totzauer, M. (Martina), Verduci, E. (Elvira), Xhonneux, A. (Annick), Zaragoza-Jordana, M. (Marta), Schwalber, A. (Amelie), Foong, R.E. (Rachel E.), Hall, G.L. (Graham L.), Lin, A. (Ashleigh), Carson, J. (Jennie), Melton, P. (Phillip), and Rauschert, S. (Sebastian)
Abstract: Early life is an important window of opportunity to improve health across the full lifecycle. An accumulating body of evidence suggests that exposure to adverse stressors during early life leads to developmental adaptations, which subsequently affect disease risk in later life. Also, geographical, socio-economic, and ethnic differences are related to health inequalities from early life onwards. To address these important public health challenges, many European pregnancy and childhood cohorts have been established over the last 30 years. The enormous wealth of data of these cohorts has led to important new biological insights and important impact for health from early life onwards. The impact of these cohorts and their data could be further increased by combining data from different cohorts. Combining data will lead to the possibility of identifying smaller effect estimates, and the opportunity to better identify risk groups and risk factors leading to disease across the lifecycle across countries. Also, it enables research on better causal understanding and modelling of life course health trajectories. The EU Child Cohort Network, established by the Horizon2020-funded LifeCycle Project, brings together nineteen pregnancy and childhood cohorts, together including more than 250,000 children and their parents. A large set of variables has been harmonised and standardized across these cohorts. The harmonized data are kept within each institution and can be accessed by external researchers through a shared federated data analysis platform using the R-based platform
Published: 2020
Full Text: View/download PDF

69. Changing care pathways and between-center practice variations in intensive care for traumatic brain injury across Europe

Author: Huijben, A.L.C.J.R.M. (Jilske), Wiegers-Groeneweg, E.J.A. (Eveline), Lingsma, H.F. (Hester), Citerio, G. (Giuseppe), Maas, A.I.R. (Andrew), Menon, D.K. (David ), Ercole, A. (Ari), Nelson, D. (David), Jagt, M. (Mathieu) van der, Steyerberg, E.W. (Ewout), Helbok, R. (Raimund), Lecky, F.E. (Fiona), Peul, W.C. (Wilco), Birg, T. (Tatiana), Zoerle, T. (Tommaso), Carbonara, M. (Marco), Stocchetti, N. (Nino), Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andelic, N. (Nada), Andreassen, L. (Lasse), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Beqiri, E. (Erta), Blaabjerg, M. (Morten), Lund, S.B. (Stine Borgen), Brorsson, C. (Camilla), Buki, A. (Andras), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Castaño-León, A.M. (Ana M.), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), DeKeyser, V. (Véronique), Degos, V. (Vincent), Della Corte, F. (Francesco), den Boogert, H. (Hugo), Depreitere, B. (Bart), Dilvesi, D. (Dula), Dixit, A. (Abhishek), Dreier, J.P. (Jens), Dulière, G.-L. (Guy-Loup), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Foks, K. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Galanaud, D. (Damien), Gantner, D. (Dashiell), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Golubovic, J. (Jagos), Gomez, P.A. (Pedro A.), Grossi, F. (Francesca), Gupta, D. (Deepak), Haitsma, I. (Iain), Helseth, E. (Eirik), Hutchinson, P.J. (Peter J.), Jankowski, S. (Stefan), Johnson, F. (Faye), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Laureys, S. (Steven), Ledoux, D. (Didier), Lejeune, A. (Aurelie), Lightfoot, R. (Roger), Manara, A. (Alex), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Menovsky, T. (Tomas), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Newcombe, V.F. (Virginia F.), Nyirádi, J. (József), Ortolano, F. (Fabrizio), Payen, J.-F. (Jean-François), Perlbarg, V. (Vincent), Persona, P. (Paolo), Piippo-Karjalainen, A. (Anna), Ples, H. (Horia), Pomposo, I. (Inigo), Posti, J.P. (Jussi P.), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rhodes, J.K.J. (Jonathan K.J.), Richter, S. (Sophie), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosenfeld, J.V. (Jeffrey V.), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Sahuquillo, J. (Juan), Sandrød, O. (Oddrun), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Schirmer-Mikalsen, K. (Kari), Schou, R. (Rico), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Sundström, N. (Nina), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Tenovuo, O. (Olli), Thomas, M. (Matt), Tibboel, D. (Dick), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Tudora, C.M. (CristinaMaria), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Van der Steen, G. (Gregory), van Wijk, R.P.J. (Roel P. J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Vulekovic, P. (Peter), Williams, G. (Guy), Winzeck, S. (Stefan), Wolf, S. (Stefan), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Clusmann, A.Z.H. (Agate Ziverte Hans), Voormolen, D.C. (Daphne), van Dijck, J.T.J.M. (Jeroen T. J. M.), van Essen, T.A. (Thomas A.), Huijben, A.L.C.J.R.M. (Jilske), Wiegers-Groeneweg, E.J.A. (Eveline), Lingsma, H.F. (Hester), Citerio, G. (Giuseppe), Maas, A.I.R. (Andrew), Menon, D.K. (David ), Ercole, A. (Ari), Nelson, D. (David), Jagt, M. (Mathieu) van der, Steyerberg, E.W. (Ewout), Helbok, R. (Raimund), Lecky, F.E. (Fiona), Peul, W.C. (Wilco), Birg, T. (Tatiana), Zoerle, T. (Tommaso), Carbonara, M. (Marco), Stocchetti, N. (Nino), Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andelic, N. (Nada), Andreassen, L. (Lasse), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Beqiri, E. (Erta), Blaabjerg, M. (Morten), Lund, S.B. (Stine Borgen), Brorsson, C. (Camilla), Buki, A. (Andras), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Castaño-León, A.M. (Ana M.), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), DeKeyser, V. (Véronique), Degos, V. (Vincent), Della Corte, F. (Francesco), den Boogert, H. (Hugo), Depreitere, B. (Bart), Dilvesi, D. (Dula), Dixit, A. (Abhishek), Dreier, J.P. (Jens), Dulière, G.-L. (Guy-Loup), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Foks, K. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Galanaud, D. (Damien), Gantner, D. (Dashiell), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Golubovic, J. (Jagos), Gomez, P.A. (Pedro A.), Grossi, F. (Francesca), Gupta, D. (Deepak), Haitsma, I. (Iain), Helseth, E. (Eirik), Hutchinson, P.J. (Peter J.), Jankowski, S. (Stefan), Johnson, F. (Faye), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Laureys, S. (Steven), Ledoux, D. (Didier), Lejeune, A. (Aurelie), Lightfoot, R. (Roger), Manara, A. (Alex), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Menovsky, T. (Tomas), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Newcombe, V.F. (Virginia F.), Nyirádi, J. (József), Ortolano, F. (Fabrizio), Payen, J.-F. (Jean-François), Perlbarg, V. (Vincent), Persona, P. (Paolo), Piippo-Karjalainen, A. (Anna), Ples, H. (Horia), Pomposo, I. (Inigo), Posti, J.P. (Jussi P.), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rhodes, J.K.J. (Jonathan K.J.), Richter, S. (Sophie), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosenfeld, J.V. (Jeffrey V.), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Sahuquillo, J. (Juan), Sandrød, O. (Oddrun), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Schirmer-Mikalsen, K. (Kari), Schou, R. (Rico), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Sundström, N. (Nina), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Tenovuo, O. (Olli), Thomas, M. (Matt), Tibboel, D. (Dick), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Tudora, C.M. (CristinaMaria), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Van der Steen, G. (Gregory), van Wijk, R.P.J. (Roel P. J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Vulekovic, P. (Peter), Williams, G. (Guy), Winzeck, S. (Stefan), Wolf, S. (Stefan), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Clusmann, A.Z.H. (Agate Ziverte Hans), Voormolen, D.C. (Daphne), van Dijck, J.T.J.M. (Jeroen T. J. M.), and van Essen, T.A. (Thomas A.)
Abstract: Purpose: To describe ICU stay, selected management aspects, and outcome of Intensive Care Unit (ICU) patients with traumatic brain injury (TBI) in Europe, and to quantify variation across centers. Methods: This is a prospective observational multicenter study conducted across 18 countries in Europe and Israel. Admission characteristics, clinical data, and outcome were described at patient- and center levels. Between-center variation in the total ICU population was quantified with the median odds ratio (MOR), with correction for case-mix and random variation between centers. Results: A total of 2138 patients were admitted to the ICU, with median age of 49 years; 36% of which were mild TBI (Glasgow Coma Scale; GCS 13–15). Within, 72 h 636 (30%) were discharged and 128 (6%) died. Early deaths and long-stay patients (> 72 h) had more severe injuries based on the GCS and neuroimaging characteristics, compared with short-stay patients. Long-stay patients received more monitoring and were treated at higher intensity, and experienced worse 6-month outcome compared to short-stay patients. Between-center variations were prominent in the proportion of short-stay patients (MOR = 2.3, p < 0.001), use of intracranial pressure (ICP) monitoring (MOR = 2.5, p < 0.001) and aggressive treatmen
Published: 2020
Full Text: View/download PDF

70. End-of-life practices in traumatic brain injury patients: Report of a questionnaire from the CENTER-TBI study

Author: van Veen, E. (Ernest), Jagt, M. (Mathieu) van der, Citerio, G. (Giuseppe), Stocchetti, N. (Nino), Epker, J.L. (Jelle), Gommers, D.A.M.P.J. (Diederik), Burdorf, L. (Lex), Menon, D.K. (David ), Maas, A.I.R. (Andrew), Lingsma, H.F. (Hester), Kompanje, E.J.O. (Erwin), van Veen, E. (Ernest), Jagt, M. (Mathieu) van der, Citerio, G. (Giuseppe), Stocchetti, N. (Nino), Epker, J.L. (Jelle), Gommers, D.A.M.P.J. (Diederik), Burdorf, L. (Lex), Menon, D.K. (David ), Maas, A.I.R. (Andrew), Lingsma, H.F. (Hester), and Kompanje, E.J.O. (Erwin)
Abstract: Purpose: We aimed to study variation regarding specific end-of-life (EoL) practices in the intensive care unit (ICU) in traumatic brain injury (TBI) patients. Materials and methods: Respondents from 67 hospitals participating in The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study completed several questionnaires on management of TBI patients. Results: In 60% of the centers, ≤50% of all patients with severe neurological damage dying in the ICU, die after withdrawal of life-sustaining measures (LSM). The decision to withhold/withdraw LSM was made following multidisciplinary consensus in every center. Legal representatives/relatives played a role in the decision-making process in 81% of the centers. In 82% of the centers, age played a role in the decision to withhold/withdraw LSM. Furthermore, palliative therapy was initiated in 79% of the centers after the decision to withdraw LSM was made. Last, withholding/withdrawing LSM was, generally, more often considered after more time had passed, in a patient with TBI, who remained in a very poor prognostic condition. Conclusion: We found variation regarding EoL practices in TBI patients. These results provide insight into variability regarding important issues pertaining to EoL practices in TBI, which can be useful to stimulate discussions on EoL practices, comparative effectiveness research, and, ultimately, development of recommendations.
Published: 2020
Full Text: View/download PDF

71. Quality indicators for patients with traumatic brain injury in European intensive care units

Author: Huijben, A.L.C.J.R.M. (Jilske), Wiegers-Groeneweg, E.J.A. (Eveline), Ercole, A. (Ari), Keizer, N.F. (Nicolette) de, Maas, A.I.R. (Andrew), Steyerberg, E.W. (Ewout), Citerio, G. (Giuseppe), Wilson, L. (Lindsay), Polinder, S. (Suzanne), Nieboer, D. (Daan), Menon, D.K. (David ), Lingsma, H.F. (Hester), Jagt, M. (Mathieu) van der, Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andelic, N. (Nada), Andreassen, L. (Lasse), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Beqiri, E. (Erta), Blaabjerg, M. (Morten), Lund, S.B. (Stine Borgen), Brorsson, C. (Camilla), Buki, A. (Andras), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Carbonara, M. (Marco), Castaño-León, A.M. (Ana M.), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), De Keyser, V. (Véronique), Degos, V. (Vincent), Corte, F.D. (Francesco Della), Den Boogert, H. (Hugo), Depreitere, B. (Bart), Dilvesi, D. (Dula), Dixit, A. (Abhishek), Dreier, J.P. (Jens), Dulière, G.-L. (Guy-Loup), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Foks, K. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Galanaud, D. (Damien), Gantner, D. (Dashiell), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Golubovic, J. (Jagos), Gomez, P.A. (Pedro A.), Grossi, F. (Francesca), Gupta, D. (Deepak), Haitsma, I. (Iain), Helbok, R. (Raimund), Helseth, E. (Eirik), Hutchinson, P.J. (Peter J.), Jankowski, S. (Stefan), Johnson, F. (Faye), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Laureys, S. (Steven), Lecky, F.E. (Fiona), Ledoux, D. (Didier), Lejeune, A. (Aurelie), Lightfoot, R. (Roger), Manara, A. (Alex), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Menovsky, T. (Tomas), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Nelson, D. (David), Newcombe, V.F. (Virginia F.), Nyirádi, J. (József), Ortolano, F. (Fabrizio), Payen, J.-F. (Jean-François), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W.C. (Wilco), Piippo-Karjalainen, A. (Anna), Ples, H. (Horia), Pomposo, I. (Inigo), Posti, J.P. (Jussi P.), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rhodes, J.K.J. (Jonathan K.J.), Richter, S. (Sophie), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosenfeld, J.V. (Jeffrey V.), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Sahuquillo, J. (Juan), Sandrød, O. (Oddrun), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Schirmer-Mikalsen, K. (Kari), Schou, R. (Rico), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stocchetti, N. (Nino), Sundström, N. (Nina), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Tenovuo, O. (Olli), Thomas, M. (Matt), Tibboel, D. (Dick), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Tudora, C.M. (Cristina Maria), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Van Der Steen, G. (Gregory), Van Dijck, J.T.J.M. (Jeroen T. J. M.), Van Essen, T.A. (Thomas A.), Van Wijk, R.P.J. (Roel P. J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Voormolen, D.C. (Daphne), Vulekovic, P. (Peter), Williams, G. (Guy), Winzeck, S. (Stefan), Wolf, S. (Stefan), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Ziverte, A. (Agate), Zoerle, T. (Tommaso), Clusmann, H. (Hans), Huijben, A.L.C.J.R.M. (Jilske), Wiegers-Groeneweg, E.J.A. (Eveline), Ercole, A. (Ari), Keizer, N.F. (Nicolette) de, Maas, A.I.R. (Andrew), Steyerberg, E.W. (Ewout), Citerio, G. (Giuseppe), Wilson, L. (Lindsay), Polinder, S. (Suzanne), Nieboer, D. (Daan), Menon, D.K. (David ), Lingsma, H.F. (Hester), Jagt, M. (Mathieu) van der, Åkerlund, C. (Cecilia), Amrein, K. (Krisztina), Andelic, N. (Nada), Andreassen, L. (Lasse), Audibert, G. (Gérard), Azouvi, P. (Philippe), Azzolini, M.L. (Maria Luisa), Bartels, R.H.M.A. (Ronald), Beer, R. (Ronny), Bellander, B.-M. (Bo-Michael), Benali, H. (Habib), Berardino, M. (Maurizio), Beretta, L. (Luigi), Beqiri, E. (Erta), Blaabjerg, M. (Morten), Lund, S.B. (Stine Borgen), Brorsson, C. (Camilla), Buki, A. (Andras), Cabeleira, M. (Manuel), Caccioppola, A. (Alessio), Calappi, E. (Emiliana), Calvi, M.R. (Maria Rosa), Cameron, P. (Peter), Lozano, G.C. (Guillermo Carbayo), Carbonara, M. (Marco), Castaño-León, A.M. (Ana M.), Cavallo, S. (Simona), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Dark, P. (Paul), De Keyser, V. (Véronique), Degos, V. (Vincent), Corte, F.D. (Francesco Della), Den Boogert, H. (Hugo), Depreitere, B. (Bart), Dilvesi, D. (Dula), Dixit, A. (Abhishek), Dreier, J.P. (Jens), Dulière, G.-L. (Guy-Loup), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Foks, K. (Kelly), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Galanaud, D. (Damien), Gantner, D. (Dashiell), Ghuysen, A. (Alexandre), Giga, L. (Lelde), Golubovic, J. (Jagos), Gomez, P.A. (Pedro A.), Grossi, F. (Francesca), Gupta, D. (Deepak), Haitsma, I. (Iain), Helbok, R. (Raimund), Helseth, E. (Eirik), Hutchinson, P.J. (Peter J.), Jankowski, S. (Stefan), Johnson, F. (Faye), Karan, M. (Mladen), Kolias, A.G. (Angelos G.), Kondziella, D. (Daniel), Koraropoulos, E. (Evgenios), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kowark, A. (Ana), Lagares, A. (Alfonso), Laureys, S. (Steven), Lecky, F.E. (Fiona), Ledoux, D. (Didier), Lejeune, A. (Aurelie), Lightfoot, R. (Roger), Manara, A. (Alex), Martino, C. (Costanza), Maréchal, H. (Hugues), Mattern, J. (Julia), McMahon, C. (Catherine), Menovsky, T. (Tomas), Misset, B. (Benoit), Muraleedharan, V. (Visakh), Murray, L. (Lynnette), Negru, A. (Ancuta), Nelson, D. (David), Newcombe, V.F. (Virginia F.), Nyirádi, J. (József), Ortolano, F. (Fabrizio), Payen, J.-F. (Jean-François), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W.C. (Wilco), Piippo-Karjalainen, A. (Anna), Ples, H. (Horia), Pomposo, I. (Inigo), Posti, J.P. (Jussi P.), Puybasset, L. (Louis), Radoi, A. (Andreea), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rhodes, J.K.J. (Jonathan K.J.), Richter, S. (Sophie), Rocka, S. (Saulius), Roe, C. (Cecilie), Roise, O. (Olav), Rosenfeld, J.V. (Jeffrey V.), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Sahuquillo, J. (Juan), Sandrød, O. (Oddrun), Sakowitz, O. (Oliver), Sanchez-Porras, R. (Renan), Schirmer-Mikalsen, K. (Kari), Schou, R. (Rico), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stocchetti, N. (Nino), Sundström, N. (Nina), Takala, R. (Riikka), Tamás, V. (Viktória), Tamosuitis, T. (Tomas), Tenovuo, O. (Olli), Thomas, M. (Matt), Tibboel, D. (Dick), Tolias, C.M. (Christos M.), Trapani, T. (Tony), Tudora, C.M. (Cristina Maria), Vajkoczy, P. (Peter), Vallance, S. (Shirley), Valeinis, E. (Egils), Vámos, Z. (Zoltán), Van Der Steen, G. (Gregory), Van Dijck, J.T.J.M. (Jeroen T. J. M.), Van Essen, T.A. (Thomas A.), Van Wijk, R.P.J. (Roel P. J.), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Vik, A. (Anne), Vilcinis, R. (Rimantas), Volovici, V. (Victor), Voormolen, D.C. (Daphne), Vulekovic, P. (Peter), Williams, G. (Guy), Winzeck, S. (Stefan), Wolf, S. (Stefan), Younsi, A. (Alexander), Zeiler, F.A. (Frederick A.), Ziverte, A. (Agate), Zoerle, T. (Tommaso), and Clusmann, H. (Hans)
Abstract: Background: The aim of this study is to validate a previously published consensus-based quality indicator set for the management of patients with traumatic brain injury (TBI) at intensive care units (ICUs) in Europe and to study its potential for quality measurement and improvement. Methods: Our analysis was based on 2006 adult patients admitted to 54 ICUs between 2014 and 2018, enrolled in the CENTER-TBI study. Indicator scores were calculated as percentage adherence for structure and process indicators and as event rates or median scores for outcome indicators. Feasibility was quantified by the completeness of the variables. Discriminability was determined by the between-centre variation, estimated with a random effect regression model adjusted for case-mix severity and quantified by the median odds ratio (MOR). Statistical uncertainty of outcome indicators was determined by the median number of events per centre, using a cut-off of 10. Results: A total of 26/42 indicators could be calculated from the CENTER-TBI database. Most quality indicators proved feasible to obtain with more than 70% completeness. Sub-optimal adherence was found for most quality indicators, ranging from 26 to 93% and 20 to 99% for structure and process indicators. Significant (p < 0.001) between-centre variation was found in seven process and five outcome indicators with MORs ranging from 1.51 to 4.14. Statistical uncertainty of outcome indicators was generally high; five out of seven had less than 10 events per centre. Conclusions: Overall, nine structures, five processes, but none of the outcome indicators showed potential for quality improvement purposes for TBI patients in the ICU. Future research should focus on implementation efforts and continuous reevaluation of quality indicators. Trial registration: The core study was registered with ClinicalTrials.gov, number NCT02210221, registered on August 06, 2014, with Resource Identification Portal (RRID: SCR_015582).
Published: 2020
Full Text: View/download PDF

72. A canonical form for positive definite matrices

Author: Dutour Sikirić, M. (Mathieu), Haensch, A. (Anna), Voight, J. (John), Woerden, W.P.J. (Wessel) van, Dutour Sikirić, M. (Mathieu), Haensch, A. (Anna), Voight, J. (John), and Woerden, W.P.J. (Wessel) van
Abstract: We exhibit an explicit, deterministic algorithm for finding a canonical form for a positive definite matrix under unimodular integral transformations. We use characteristic sets of short vectors and partition-backtracking graph software. The algorithm runs in a number of arithmetic operations that is exponential in the dimension n, but it is practical and more efficient than canonical forms based on Minkowski reduction.
Published: 2020
Full Text: View/download PDF

73. Variation in monitoring and treatment policies for intracranial hypertension in traumatic brain injury: A survey in 66 neurotrauma centers participating in the CENTER-TBI study

Author: Cnossen, M.C. (Maryse), Huijben, J.A. (Jilske A.), van der Jagt, M. (Mathieu), Volovici, V. (Victor), van Essen, T. (Thomas), Polinder, S. (Suzanne), Nelson, D. (David), Ercole, A. (Ari), Stocchetti, N. (Nino), Citerio, G. (Giuseppe), Peul, W.C. (Wilco), Maas, A.I.R. (Andrew), Menon, D.K. (David ), Steyerberg, E.W. (Ewout), Lingsma, H.F. (Hester F.), Adams, H. (Hadie), Alessandro, M. (Masala), Allanson, J.E. (Judith), Amrein, K. (Krisztina), Andaluz, N. (Norberto), Andelic, N. (Nada), Andrea, N. (Nanni), Andreassen, L. (Lasse), Anke, A. (Audny), Antoni, A. (Anna), Ardon, H. (Hilko), Audibert, G. (Gérard), Auslands, K. (Kaspars), Azouvi, P. (Philippe), Baciu, C. (Camelia), Bacon, A. (Andrew), Badenes, R. (Rafael), Baglin, T. (Trevor), Bartels, R.H.M.A. (Ronald), Barzo, P. (P.), Bauerfeind, U. (Ursula), Beer, R. (Ronny), Belda, F.J. (Francisco Javier), Bellander, B.-M. (Bo-Michael), Belli, A. (Antonio), Bellier, R. (Rémy), Benali, H. (Habib), Benard, T. (Thierry), Berardino, M. (Maurizio), Beretta, L. (Luigi), Beynon, C. (Christopher), Bilotta, F. (Federico), Binder, H. (Harald), Biqiri, E. (Erta), Blaabjerg, M. (Morten), Lund, S.B. (Stine Borgen), Bouzat, P. (Pierre), Bragge, P. (Peter), Brazinova, A. (Alexandra), Brehar, F. (Felix), Brorsson, C. (Camilla), Buki, A. (Andras), Bullinger, M. (Monika), Bucková, V. (Veronika), Calappi, E. (Emiliana), Cameron, P. (Peter), Carbayo, L.G. (Lozano Guillermo), Carise, E. (Elsa), Carpenter, K.L.H. (Keri L.H.), Castaño-León, A.M. (Ana M.), Causin, F. (Francesco), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Cnossen, M. (Maryse), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Covic, A. (Amra), Curry, N. (Nicola), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Damas, F. (François), Damas, P. (Pierre), Dawes, H. (Helen), De Keyser, V. (Véronique), Corte, F.D. (Francesco), Depreitere, B. (Bart), Ding, S. (Shenghao), Dippel, D.W.J. (Diederik), Dizdarevic, K. (Kemal), Dulière, G.-L. (Guy-Loup), Dzeko, A. (Adelaida), Eapen, G. (George), Engemann, H. (Heiko), Esser, P. (Patrick), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Feigin, V.L. (V.), Feng, J. (Junfeng), Foks, K. (Kelly), Fossi, F. (Francesca), Francony, G. (Gilles), Frantzén, J. (Janek), Freo, U. (Ulderico), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Gagliardo, P. (Pablo), Galanaud, D. (Damien), Gao, G. (Guoyi), Geleijns, K. (Karin), Ghuysen, A. (Alexandre), Giraud, B. (Benoit), Glocker, B. (Ben), Gomez, P.A. (Pedro A.), Grossi, F. (Francesca), Gruen, R.L. (Russell), Gupta, D. (Deepak), Haagsma, J.A. (Juanita), Hadzic, E. (Ermin), Haitsma, I. (Iain), Hartings, J.A. (Jed), Helbok, R. (Raimund), Helseth, E. (Eirik), Hertle, D. (Daniel), Hill, S. (Sean), Hoedemaekers, A. (Astrid), Hoefer, S. (Stefan), Hutchinson, P.J. (Peter J.), Håberg, K.A. (Kristine Asta), Jacobs, B.C. (Bart), Janciak, I. (Ivan), Janssens, K. (Koen), Jiang, J.-Y. (Ji-Yao), Jones, K. (Kelly), Kalala, J.-P. (Jean-Pierre), Kamnitsas, K. (Konstantinos), Karan, M. (Mladen), Karau, J. (Jana), Katila, A. (Ari), Kaukonen, M. (Maija), Keeling, D. (David), Kerforne, T. (Thomas), Ketharanathan, N. (Naomi), Kettunen, J. (Johannes), Kivisaari, R. (Riku), Kolias, A.G. (Angelos G.), Kolumbán, B. (Bálint), Kompanje, E.J.O. (Erwin), Kondziella, D. (Daniel), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kalovits, F. (Ferenc), Lagares, A. (Alfonso), Lanyon, L. (Linda), Laureys, S. (Steven), Lauritzen, M. (Martin), Lecky, F.E. (Fiona), Ledig, C. (Christian), Lefering, R., Legrand, V. (Valerie), Lei, J. (Jin), Levi, L. (Leon), Lightfoot, R. (Roger), Lingsma, H.F. (Hester), Loeckx, D. (Dirk), Lozano, A. (Angels), Luddington, R. (Roger), Luijten-Arts, C. (Chantal), Maas, A.I.R. (Andrew I.R.), MacDonald, S. (Stephen), MacFayden, C. (Charles), Maegele, M. (Marc), Majdan, M. (Marek), Major, S. (Sebastian), Manara, A. (Alex), Manhes, P. (Pauline), Manley, G. (Geoffrey), Martin, D. (Didier), Martino, C. (Costanza), Maruenda, A. (Armando), Maréchal, H. (Hugues), Mastelova, D. (Dagmara), Mattern, J. (Julia), McMahon, C. (Catherine), Melegh, B. (Béla), Menon, D. (David), Menovsky, T. (Tomas), Morganti-Kossmann, C. (Cristina), Mulazzi, D. (Davide), Mutschler, M. (Manuel), Mühlan, H. (Holger), Negru, A. (Ancuta), Neugebauer, E. (Eddy), Newcombe, V.F. (Virginia F.), Noirhomme, Q. (Quentin), Nyirádi, J. (József), Oddo, M. (Mauro), Oldenbeuving, A.W., Oresic, M. (Matej), Ortolano, F. (Fabrizio), Palotie, A. (Aarno), Parizel, P.M., Patruno, A. (Adriana), Payen, J.-F. (Jean-François), Perera, N. (Natascha), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W. (Wilco), Pichon, N. (Nicolas), Piilgaard, H. (Henning), Piippo, A. (Anna), Floury, S.P. (Sébastien Pili), Pirinen, M. (Matti), Ples, H. (Horia), Pomposo, I. (Inigo), Psota, M. (Marek), Pullens, P. (Pim), Puybasset, L. (Louis), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rambadagalla, M. (Malinka), Rehorcíková, V. (Veronika), Rhodes, J.K.J. (Jonathan K.J.), Richardson, S. (Sylvia), Ripatti, S. (Samuli), Rocka, S. (Saulius), Rodier, N. (Nicolas), Roe, C. (Cecilie), Roise, O. (Olav), Roks, C.M.A.A. (Gerwin), Romegoux, P. (Pauline), Rosand, J. (Jonathan), Rosenfeld, J. (Jeffrey), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Rostalski, T. (Tim), Rueckert, D. (Daniel), de Ruiz, A.F. (Arcaute Felix), Rusnák, M. (Martin), Sacchi, M. (Marco), Sahakian, B. (Barbara), Sahuquillo, J. (Juan), Sakowitz, O. (Oliver), Sala, F. (Francesca), Sanchez-Pena, P. (Paola), Sanchez-Porras, R. (Renan), Sandor, J. (Janos), Santos, E. (Edgar), Sasse, N. (Nadine), Sasu, L. (Luminita), Savo, D. (Davide), Schipper, I.B. (Inger), Schlößer, B. (Barbara), Schmidt, S. (Silke), Schneider, A. (Annette), Schoechl, H. (Herbert), Schoonman, G.G. (Guus), Rico, F.S. (Frederik Schou), Schwendenwein, E. (Elisabeth), Schöll, M. (Michael), Sir, O. (özcan), Skandsen, T. (Toril), Smakman, L. (Lidwien), Smeets, D. (Dominique), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stanworth, S. (Simon), Stegemann, K. (Katrin), Steinbüchel, N. (Nicole), Stevens, R. (Robert), Stewart, W. (William), Sundström, N. (Nina), Synnot, A. (Anneliese), Szabó, J. (József), Söderberg, J. (Jeannette), Taccone, F.S. (Fabio), Tamás, V. (Viktória), Tanskanen, P. (Päivi), Tascu, A. (Alexandru), Taylor, M.S. (Mark Steven), Te, A.B. (Ao Braden), Tenovuo, O. (Olli), Teodorani, G. (Guido), Theadom, A. (Alice), Thomas, M. (Matt), Tibboel, D. (Dick), Tolias, C.M. (Christos M.), Tshibanda, J.-F.L. (Jean-Flory Luaba), Tudora, C.M. (Cristina Maria), Vajkoczy, P. (Peter), Valeinis, E. (Egils), Hecke, W.V. (Wim Van), Praag, D.V. (Dominique Van), Dirk, V.R. (Van Roost), Vlierberghe, E.V. (Eline Van), Vyvere, T.V. (Thijs vande), Vanhaudenhuyse, A. (Audrey), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Verheyden, J. (Jan), Vespa, P.M. (Paul M.), Vik, A. (Anne), Vilcinis, R. (Rimantas), Vizzino, G. (Giacinta), Vleggeert-Lankamp, C.L.A.M. (Carmen), Vulekovic, P. (Peter), Vámos, Z. (Zoltán), Wade, D. (Derick), Wang, K.K.W. (Kevin K.W.), Wang, L. (Lei), Wildschut, E.D. (Enno), Williams, G. (Guy), Willumsen, L. (Lisette), Wilson, A. (Adam), Wilson, L. (Lindsay), Winkler, M.K.L. (Maren K.L.), Ylén, P. (Peter), Younsi, A. (Alexander), Zaaroor, M. (Menashe), Zhang, Z. (Zhiqun), Zheng, Z. (Zelong), Zumbo, F. (Fabrizio), de Lange, S. (Stefanie), De Ruiter, G.C.W. (Godard C.W.), den Boogert, H. (Hugo), van Dijck, J. (Jeroen), Essen, T.A. (T.) van, van Heugten, C.M. (Caroline M.), Jagt, M. (Mathieu) van der, Naalt, J. (Joukje) van der, Cnossen, M.C. (Maryse), Huijben, J.A. (Jilske A.), van der Jagt, M. (Mathieu), Volovici, V. (Victor), van Essen, T. (Thomas), Polinder, S. (Suzanne), Nelson, D. (David), Ercole, A. (Ari), Stocchetti, N. (Nino), Citerio, G. (Giuseppe), Peul, W.C. (Wilco), Maas, A.I.R. (Andrew), Menon, D.K. (David ), Steyerberg, E.W. (Ewout), Lingsma, H.F. (Hester F.), Adams, H. (Hadie), Alessandro, M. (Masala), Allanson, J.E. (Judith), Amrein, K. (Krisztina), Andaluz, N. (Norberto), Andelic, N. (Nada), Andrea, N. (Nanni), Andreassen, L. (Lasse), Anke, A. (Audny), Antoni, A. (Anna), Ardon, H. (Hilko), Audibert, G. (Gérard), Auslands, K. (Kaspars), Azouvi, P. (Philippe), Baciu, C. (Camelia), Bacon, A. (Andrew), Badenes, R. (Rafael), Baglin, T. (Trevor), Bartels, R.H.M.A. (Ronald), Barzo, P. (P.), Bauerfeind, U. (Ursula), Beer, R. (Ronny), Belda, F.J. (Francisco Javier), Bellander, B.-M. (Bo-Michael), Belli, A. (Antonio), Bellier, R. (Rémy), Benali, H. (Habib), Benard, T. (Thierry), Berardino, M. (Maurizio), Beretta, L. (Luigi), Beynon, C. (Christopher), Bilotta, F. (Federico), Binder, H. (Harald), Biqiri, E. (Erta), Blaabjerg, M. (Morten), Lund, S.B. (Stine Borgen), Bouzat, P. (Pierre), Bragge, P. (Peter), Brazinova, A. (Alexandra), Brehar, F. (Felix), Brorsson, C. (Camilla), Buki, A. (Andras), Bullinger, M. (Monika), Bucková, V. (Veronika), Calappi, E. (Emiliana), Cameron, P. (Peter), Carbayo, L.G. (Lozano Guillermo), Carise, E. (Elsa), Carpenter, K.L.H. (Keri L.H.), Castaño-León, A.M. (Ana M.), Causin, F. (Francesco), Chevallard, G. (Giorgio), Chieregato, A. (Arturo), Cnossen, M. (Maryse), Coburn, M. (Mark), Coles, J.P. (Jonathan P.), Cooper, J.D. (Jamie D.), Correia, M. (Marta), Covic, A. (Amra), Curry, N. (Nicola), Czeiter, E. (Endre), Czosnyka, M. (Marek), Dahyot-Fizelier, C. (Claire), Damas, F. (François), Damas, P. (Pierre), Dawes, H. (Helen), De Keyser, V. (Véronique), Corte, F.D. (Francesco), Depreitere, B. (Bart), Ding, S. (Shenghao), Dippel, D.W.J. (Diederik), Dizdarevic, K. (Kemal), Dulière, G.-L. (Guy-Loup), Dzeko, A. (Adelaida), Eapen, G. (George), Engemann, H. (Heiko), Esser, P. (Patrick), Ezer, E. (Erzsébet), Fabricius, M. (Martin), Feigin, V.L. (V.), Feng, J. (Junfeng), Foks, K. (Kelly), Fossi, F. (Francesca), Francony, G. (Gilles), Frantzén, J. (Janek), Freo, U. (Ulderico), Frisvold, S.K. (Shirin Kordasti), Furmanov, A. (Alex), Gagliardo, P. (Pablo), Galanaud, D. (Damien), Gao, G. (Guoyi), Geleijns, K. (Karin), Ghuysen, A. (Alexandre), Giraud, B. (Benoit), Glocker, B. (Ben), Gomez, P.A. (Pedro A.), Grossi, F. (Francesca), Gruen, R.L. (Russell), Gupta, D. (Deepak), Haagsma, J.A. (Juanita), Hadzic, E. (Ermin), Haitsma, I. (Iain), Hartings, J.A. (Jed), Helbok, R. (Raimund), Helseth, E. (Eirik), Hertle, D. (Daniel), Hill, S. (Sean), Hoedemaekers, A. (Astrid), Hoefer, S. (Stefan), Hutchinson, P.J. (Peter J.), Håberg, K.A. (Kristine Asta), Jacobs, B.C. (Bart), Janciak, I. (Ivan), Janssens, K. (Koen), Jiang, J.-Y. (Ji-Yao), Jones, K. (Kelly), Kalala, J.-P. (Jean-Pierre), Kamnitsas, K. (Konstantinos), Karan, M. (Mladen), Karau, J. (Jana), Katila, A. (Ari), Kaukonen, M. (Maija), Keeling, D. (David), Kerforne, T. (Thomas), Ketharanathan, N. (Naomi), Kettunen, J. (Johannes), Kivisaari, R. (Riku), Kolias, A.G. (Angelos G.), Kolumbán, B. (Bálint), Kompanje, E.J.O. (Erwin), Kondziella, D. (Daniel), Koskinen, L.-O. (Lars-Owe), Kovács, N. (Noémi), Kalovits, F. (Ferenc), Lagares, A. (Alfonso), Lanyon, L. (Linda), Laureys, S. (Steven), Lauritzen, M. (Martin), Lecky, F.E. (Fiona), Ledig, C. (Christian), Lefering, R., Legrand, V. (Valerie), Lei, J. (Jin), Levi, L. (Leon), Lightfoot, R. (Roger), Lingsma, H.F. (Hester), Loeckx, D. (Dirk), Lozano, A. (Angels), Luddington, R. (Roger), Luijten-Arts, C. (Chantal), Maas, A.I.R. (Andrew I.R.), MacDonald, S. (Stephen), MacFayden, C. (Charles), Maegele, M. (Marc), Majdan, M. (Marek), Major, S. (Sebastian), Manara, A. (Alex), Manhes, P. (Pauline), Manley, G. (Geoffrey), Martin, D. (Didier), Martino, C. (Costanza), Maruenda, A. (Armando), Maréchal, H. (Hugues), Mastelova, D. (Dagmara), Mattern, J. (Julia), McMahon, C. (Catherine), Melegh, B. (Béla), Menon, D. (David), Menovsky, T. (Tomas), Morganti-Kossmann, C. (Cristina), Mulazzi, D. (Davide), Mutschler, M. (Manuel), Mühlan, H. (Holger), Negru, A. (Ancuta), Neugebauer, E. (Eddy), Newcombe, V.F. (Virginia F.), Noirhomme, Q. (Quentin), Nyirádi, J. (József), Oddo, M. (Mauro), Oldenbeuving, A.W., Oresic, M. (Matej), Ortolano, F. (Fabrizio), Palotie, A. (Aarno), Parizel, P.M., Patruno, A. (Adriana), Payen, J.-F. (Jean-François), Perera, N. (Natascha), Perlbarg, V. (Vincent), Persona, P. (Paolo), Peul, W. (Wilco), Pichon, N. (Nicolas), Piilgaard, H. (Henning), Piippo, A. (Anna), Floury, S.P. (Sébastien Pili), Pirinen, M. (Matti), Ples, H. (Horia), Pomposo, I. (Inigo), Psota, M. (Marek), Pullens, P. (Pim), Puybasset, L. (Louis), Ragauskas, A. (Arminas), Raj, R. (Rahul), Rambadagalla, M. (Malinka), Rehorcíková, V. (Veronika), Rhodes, J.K.J. (Jonathan K.J.), Richardson, S. (Sylvia), Ripatti, S. (Samuli), Rocka, S. (Saulius), Rodier, N. (Nicolas), Roe, C. (Cecilie), Roise, O. (Olav), Roks, C.M.A.A. (Gerwin), Romegoux, P. (Pauline), Rosand, J. (Jonathan), Rosenfeld, J. (Jeffrey), Rosenlund, C. (Christina), Rosenthal, G. (Guy), Rossaint, R. (Rolf), Rossi, S. (Sandra), Rostalski, T. (Tim), Rueckert, D. (Daniel), de Ruiz, A.F. (Arcaute Felix), Rusnák, M. (Martin), Sacchi, M. (Marco), Sahakian, B. (Barbara), Sahuquillo, J. (Juan), Sakowitz, O. (Oliver), Sala, F. (Francesca), Sanchez-Pena, P. (Paola), Sanchez-Porras, R. (Renan), Sandor, J. (Janos), Santos, E. (Edgar), Sasse, N. (Nadine), Sasu, L. (Luminita), Savo, D. (Davide), Schipper, I.B. (Inger), Schlößer, B. (Barbara), Schmidt, S. (Silke), Schneider, A. (Annette), Schoechl, H. (Herbert), Schoonman, G.G. (Guus), Rico, F.S. (Frederik Schou), Schwendenwein, E. (Elisabeth), Schöll, M. (Michael), Sir, O. (özcan), Skandsen, T. (Toril), Smakman, L. (Lidwien), Smeets, D. (Dominique), Smielewski, P. (Peter), Sorinola, A. (Abayomi), Stamatakis, E. (Emmanuel), Stanworth, S. (Simon), Stegemann, K. (Katrin), Steinbüchel, N. (Nicole), Stevens, R. (Robert), Stewart, W. (William), Sundström, N. (Nina), Synnot, A. (Anneliese), Szabó, J. (József), Söderberg, J. (Jeannette), Taccone, F.S. (Fabio), Tamás, V. (Viktória), Tanskanen, P. (Päivi), Tascu, A. (Alexandru), Taylor, M.S. (Mark Steven), Te, A.B. (Ao Braden), Tenovuo, O. (Olli), Teodorani, G. (Guido), Theadom, A. (Alice), Thomas, M. (Matt), Tibboel, D. (Dick), Tolias, C.M. (Christos M.), Tshibanda, J.-F.L. (Jean-Flory Luaba), Tudora, C.M. (Cristina Maria), Vajkoczy, P. (Peter), Valeinis, E. (Egils), Hecke, W.V. (Wim Van), Praag, D.V. (Dominique Van), Dirk, V.R. (Van Roost), Vlierberghe, E.V. (Eline Van), Vyvere, T.V. (Thijs vande), Vanhaudenhuyse, A. (Audrey), Vargiolu, A. (Alessia), Vega, E. (Emmanuel), Verheyden, J. (Jan), Vespa, P.M. (Paul M.), Vik, A. (Anne), Vilcinis, R. (Rimantas), Vizzino, G. (Giacinta), Vleggeert-Lankamp, C.L.A.M. (Carmen), Vulekovic, P. (Peter), Vámos, Z. (Zoltán), Wade, D. (Derick), Wang, K.K.W. (Kevin K.W.), Wang, L. (Lei), Wildschut, E.D. (Enno), Williams, G. (Guy), Willumsen, L. (Lisette), Wilson, A. (Adam), Wilson, L. (Lindsay), Winkler, M.K.L. (Maren K.L.), Ylén, P. (Peter), Younsi, A. (Alexander), Zaaroor, M. (Menashe), Zhang, Z. (Zhiqun), Zheng, Z. (Zelong), Zumbo, F. (Fabrizio), de Lange, S. (Stefanie), De Ruiter, G.C.W. (Godard C.W.), den Boogert, H. (Hugo), van Dijck, J. (Jeroen), Essen, T.A. (T.) van, van Heugten, C.M. (Caroline M.), Jagt, M. (Mathieu) van der, and Naalt, J. (Joukje) van der
Abstract: Background: No definitive evidence exists on how intracranial hypertension should be treated in patients with traumatic brain injury (TBI). It is therefore likely that centers and practitioners individually balance potential benefits and risks of different intracranial pressure (ICP) management strategies, resulting in practice variation. The aim of this study was to examine variation in monitoring and treatment policies for intracranial hypertension in patients with TBI. Methods: A 29-item survey on ICP monitoring and treatment was developed on the basis of literature and expert opinion, and it was pilot-tested in 16 centers. The questionnaire was sent to 68 neurotrauma centers participating in the Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. Results: The survey was completed by 66 centers (97% response rate). Centers were mainly academic hospitals (n=60, 91%) and designated level I trauma centers (n=44, 67%). The Brain Trauma Foundation guidelines were used in 49 (74%) centers. Approximately 90% of the participants (n=58) indicated placing an ICP monitor in patients with severe TBI and computed tomographic abnormalities. There was no consensus on other indications or on peri-insertion precautions. We found wide variation in the use of first- and second-tier treatments for elevated ICP. Approximately half of the centers were classified as using a relatively aggressive approach to ICP monitoring and treatment (n=32, 48%), whereas the others were considered more conservative (n=34, 52%). Conclusions: Substantial variation was found regarding monitoring and treatment policies in patients with TBI and intracranial hypertension. The results of this survey indicate a lack of consensus between European neurotrauma centers and provide an opportunity and necessity for comparative effectiveness research.
Published: 2017
Full Text: View/download PDF

74. Strategies for successful monitoring of CAR T-cells by flow cytometry

Author: V. Litwin, L. Hanafi, M. Mathieu, P. Pouliot, and P. Boulais
Subjects: Cancer Research, Transplantation, medicine.diagnostic_test, Computer science, Immunology, Cell Biology, Computational biology, Assay sensitivity, Chimeric antigen receptor, Flow cytometry, Oncology, medicine, Immunology and Allergy, In patient, Car t cells, Control sample, Genetics (clinical)
Abstract: Background & Aim As the success of Chimeric Antigen Receptor T-cell (CAR T-cell) therapies continues and more cell products enter clinical development, the need for robust measurements of these “living drugs” increases. The flow cytometry platform is ideally suited for characterization of cellular therapies owing to its highly specific multiplexing capabilities. Methods, Results & Conclusion Characterization of cellular therapies includes immunophenotypic characterization of CAR T-cells and other cellular components of the infusion product, as well as cellular tracking and quantification following infusion in treated patients. Nonetheless, flow cytometric analysis of CAR T-cells presents unique challenges in addition to those that are present in all other clinical and non-clinical flow assays. The primary challenges associated with monitoring of CAR T-cells post-infusion include: identifying and/or producing reagents and staining methodology for specific CAR-T cell detection; establishing appropriate assay sensitivity in patients lymphodepleted following treatment; maintaining assay specificity with CAR antigen down-regulation in vivo; establishing the accuracy of cell counting methods; defining an appropriate quality control sample for longitudinal monitoring. In this poster we describe these challenges and propose solutions for mitigation. In addition, we present recommendations for method validation aligned with the Context-of-Use as described in the new Clinical Laboratory and Standards Institute's new guidelines for the Validation of Methods Preformed by Flow Cytometry, CLSI H62.
Published: 2020
Full Text: View/download PDF

75. ICES WORKSHOP ON METHODOLOGIES FOR NEPHROPS REFERENCE POINTS (ICES WKNEPHROPS 2019) (26-28 Nov 2019)

Author: Aristegui-Ezquibela, M. (Mikel), Bell, Ewen, Bell, Michael, Cook, Robin, Dobby, H. (Helen), Fifas, S. (Spyros), González-Herraiz, I. (Isabel), Lordan, C. (Colm), Lundy, M. (Mathieu), Nawri, Nikolai, Santana, Cesar, Silva, C. (Cristina), and Vila, Y. (Yolanda)
Subjects: Pesquerías, Centro Oceanográfico de A Coruña
Published: 2019

76. Decision criteria influencing the therapeutic approach to invasive cervical resorption: a case series

Author: Ehlinger, C. (Claire), Ginies, E. (Estelle), Bornert, F. (Fabien), Bahi-gross, S. (Sophie), Schmittbuhl, M. (Mathieu), Minoux, M. (Maryline), Nanomédecine Régénérative (NanoRegMed), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biomatériaux et Bioingénierie (BB), Université de Strasbourg (UNISTRA)-Matériaux et nanosciences d'Alsace (FMNGE), and Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Subjects: Sciences du Vivant [q-bio]/Médecine humaine et pathologie, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract: Invasive cervical resorption (ICR) is a dental lesion starting in the cervical region and involving the loss of dental hard tissue as a result of odontoclastic action. Due to its localization and invasive pattern, this process represents a challenging clinical situation. When feasible, the major aim of an ICR treatment is to completely remove the pathologic tissue (specifically at the entry point of the lesion) and to seal the resulting defect, without compromising tooth rehabilitation. In this context, choosing how to access the resorptive lacuna is essential. Two main options have been described in the literature: an external approach, requiring the surgical exposure of the resorptive lacuna, and an internal approach, taking advantage of the endodontic access cavity. However, there are no guidelines that indicate which approach to choose for the treatment of an ICR. This article is based on four clinical cases. It aims to provide specific clinical and radiologic features that should be considered in order to take the most appropriate decision, when choosing between the internal and the external approaches. It is proposed to base the therapeutic strategy on the accessibility and the size of the portal of entry of the lesion. When the entry point is wide, its extension along the root must also be taken into account. Other important parameters are the circumferential and vertical extents of the lesion in the radicular dentin. Although it is not a determining factor, the pulpal involvement of the lesion can also be considered. journal article 2019 imported
Published: 2019
Full Text: View/download PDF

77. ICES Scientific Reports. WORKING GROUP ON MIXED FISHERIES ADVICE METHODOLOGY

Author: Aristegui, M., Bouch, P., Brunel, T. (Thomas), Cole, H. (Harriet), Dolder, P., Garcia, D., Kalinina, O., Lundy, M. (Mathieu), Millar, Colin, Pawlowski, L. (Lionel), Robert, M., and Silva, C.
Subjects: Sede Central IEO, Pesquerías
Abstract: The ICES Working Group on Mixed Fisheries Methodology (WGMIXFISH-METHODS) annual meeting centred on the improvement of the mixed fisheries advice production process, through increasing quality, transparency and reproducibility. Two ecoregions (Celtic Sea and North Sea) have begun the move to the Transparent Assessment Framework (TAF). Gaps in documentation were identified and are now listed for improvement over the coming year. Data call changes have been proposed to ensure WGMIXFISH have the tools required to meet the growing demand for information on biological and technical interactions. Additionally, working group identified, discussed and tested new techniques in the field of mixed fisheries assessment (VAST, spatial targeting index). The number of areas assessed by the working group increased with the addition of an Irish Sea (27.7.a) FCube model. Collaboration continued with other groups, which was driven by the groups growing need for quality economic information (WGECON), and tools for visualization and exploration of mixed fisheries trends (WKTarget, Infomatics). Finally, major concerns have been raised about the suitability and completeness of extracts from the Regional Database (RDB). These finding will be shared with the Regional Database and Estimation System (RDBES) development group
Published: 2019

78. ICES. 2020. Working Group on Acoustic and Egg Surveys for Sardine and Anchovy in ICES areas 7, 8 and 9

Author: Amorin, P., Boyra, G. (Guillermo), Carrera, P. (Pablo), Díaz, P., O'Donnell, C. (Ciaran), Doray, M. (Mathieu), Duhamel, D., Huret M., Ibaibarriaga L. L., Jiménez, P., Angélico, M.M., Moreno, A., Nunes, C. (Cristina), Pawlowski, L. (Lionel), Ramos, F. (Fernando), Riveiro, I. (Isabel), Rodríguez, S. Maria Santos, Silva, A. (Alexandra), Andrés, Uriarte, and Jeroen, Vankooij
Published: 2019

79. As We Are Blind

Author: Allegraud, P. (Pierre), Béland, V. (Véronique), Denimal, Q. (Quentin), Giraud, M. (Mathieu), Groult, R. (Richard), Leguy, E. (Emmanuel), Libersat, G. (Guillaume), Université de Lille, CNRS, Centrale Lille, Algomus, Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189 [CRIStAL], and Modélisation, Information et Systèmes - UR UPJV 4290 [MIS]
Abstract: « As We Are Blind » (2016) est une installation pour « piano mécanique et aura » de Véronique Béland. Au centre d’une pièce à la scénographie épurée, un piano à queue joue la partition la plus intime : celle du spectateur. Conductance, température de la peau, poids de la main, rythme cardiaque... Chaque participant pose la main sur un capteur, et « As We Are Blind » calcule et interprète une production musicale et photographique unique, qui révèle l’« aura » colorée de chaque spectateur.
Published: 2019

80. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations

Author: Laurent Gouya, Y. Troadec, P. De Groote, M. Mathieu Dramard, Flavie Ader, Jean François Pruny, D. Dupin Deguine, Diala Khraiche, P. Charron, P. Reant, Eric Villard, Caroline Rambaud, Xavier Jeunemaitre, Pascale Richard, and L. Van Maldergem
Subjects: medicine.medical_specialty, business.industry, Cardiomyopathy, Dilated cardiomyopathy, medicine.disease, Sudden cardiac death, Internal medicine, Heart failure, Genotype, Medicine, Missense mutation, FLNC, Family history, Cardiology and Cardiovascular Medicine, business
Abstract: Background/Introduction Pathogenic variantsin FLNC encoding filamin C have been firstly reported to cause myopathies, and were recently linked to isolated cardiac phenotypes. Purpose Our aim was to estimate the prevalence of FLNC pathogenic variants in cardiomyopathies and to study the relations between phenotype and genotype. Methods DNAs from a cohort of 1150 unrelated index-patients with an isolated cardiomyopathy (700 hypertrophic, 300 dilated, 50 restrictive cardiomyopathies, and 100 left ventricle non-compactions) have been sequenced on a custom panel of 52 cardiomyopathy disease-causing genes. Results A FLNC pathogenic variant was identified in 28 patients corresponding to a prevalence ranging from 1 to 8% depending on the cardiomyopathy subtypes. Truncating variants were always identified in patients with dilated cardiomyopathy, while missense or in-frame variants were found in other phenotypes. This work reported for the first time a left ventricular non-compaction associated with FLNC pathogenic variant. In the cohort, nine patients (32%) were implanted with an automatic defibrillator. In 7 families (25%), history of sudden cardiac death (SCD) before 50 years was reported. A personal or family history of sudden cardiac death (SCD) was significantly higher in patients with truncating variants than in patients carrying missense variants (P = 0.01). Four patients died of cardiac cause including 3 from SCD and 1 from heart failure. Conclusion This work highlights the role of FLNC in cardiomyopathies. A correlation between the type of the variant and the cardiomyopathy subtype was observed as well as with SCD risk. These new data should be taken into consideration for patient's management and primary prevention of sudden cardiac death.
Published: 2020
Full Text: View/download PDF

81. Die katholischen Kirchenleiter und die weltliche Obrigkeit in der Republik der Sieben Vereinigten Provinzen

Author: Spiertz, M. (Mathieu) and Universitäts- und Landesbibliothek Münster
Subjects: Benelux
Published: 2018

82. Steroidogenic differentiation and PKA signaling are programmed by histone methyltransferase EZH2 in the adrenal cortex

Author: M, Mathieu, primary, C, Drelon, additional, S, Rodriguez, additional, H, Tabbal, additional, A, Septier, additional, C, Damon-Soubeyrand, additional, T, Dumontet, additional, A, Berthon, additional, I, Sahut-Barnola, additional, C, Djari, additional, M, Batisse-Lignier, additional, JC, Pointud, additional, D, Richard, additional, G, Kerdivel, additional, MA, Calmejane, additional, V, Boeva, additional, I, Tauveron, additional, AM, Lefrancois-Martinez, additional, A, Martinez, additional, and P, Val, additional
Published: 2019
Full Text: View/download PDF

83. Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study

Author: Harrois, A., Anstey, J.R., Taccone, F.S. (Fabio), Udy, A.A., Citerio, G, Duranteau, J, Ichai, C, Badenes, R., Prowle, J.R., Ercole, A, Oddo, M., Schneider, A. (Anne), Jagt, M. (Mathieu) van der, Wolf, S. (Sarah), Helbok, R., Nelson, D.W., Skrifvars, M.B., Cooper, D.J., Bellomo, R., Long, K., Rodrigues, A., Lozano, A., Saxby, E., Vargiolu, A., Quintard, H., Robba, C., Sisson, A., Allen, G., Baro, N., Kofler, M., Harrois, A., Anstey, J.R., Taccone, F.S. (Fabio), Udy, A.A., Citerio, G, Duranteau, J, Ichai, C, Badenes, R., Prowle, J.R., Ercole, A, Oddo, M., Schneider, A. (Anne), Jagt, M. (Mathieu) van der, Wolf, S. (Sarah), Helbok, R., Nelson, D.W., Skrifvars, M.B., Cooper, D.J., Bellomo, R., Long, K., Rodrigues, A., Lozano, A., Saxby, E., Vargiolu, A., Quintard, H., Robba, C., Sisson, A., Allen, G., Baro, N., and Kofler, M.
Abstract: Background: In traumatic brain injury (TBI) patients desmopressin administration may induce rapid decreases in serum sodium and increase intracranial pressure (ICP). Aim: In an international multi-centre study, we aimed to report changes in serum sodium and ICP after desmopressin administration in TBI patients. Methods: We obtained data from 14 neurotrauma ICUs in Europe, Australia and UK for severe TBI patients (GCS≤8) requiring ICP monitoring. We identifed patients who received any desmopressin and recorded daily dose, 6-hourly serum sodium, and 6-hourly ICP. Results: We studied 262 severe TBI patients. Of these, 39 patients (14.9%) received desmopre
Published: 2019
Full Text: View/download PDF

84. Correction to: Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study (Annals of Intensive Care, (2019), 9, 1, (99), 10.1186/s13613-019-0574-z)

Author: Harrois, A., Anstey, J.R. (J. R.), Taccone, F.S. (Fabio), Udy, A.A. (A. A.), Citerio, G. (Giuseppe), Duranteau, J. (Jacques), Ichai, C. (Carole), Badenes, R. (R.), Prowle, J.R. (J. R.), Ercole, A. (Ari), Oddo, M. (Mauro), Schneider, A. (A.), Jagt, M. (Mathieu) van der, Wolf, S. (Stefan), Helbok, R. (Raimund), Nelson, D. (David), Skrifvars, M.B. (M. B.), Cooper, D.J. (D. J.), Bellomo, R. (R.), Long, K. (K.), Rodrigues, A. (A.), Lozano, A. (A.), Saxby, E. (E.), Vargiolu, A. (Alessia), Quintard, H. (H.), Robba, C. (C.), Sisson, A. (A.), Allen, G. (G.), Baro, N. (N.), Kofler, M. (M.), Harrois, A., Anstey, J.R. (J. R.), Taccone, F.S. (Fabio), Udy, A.A. (A. A.), Citerio, G. (Giuseppe), Duranteau, J. (Jacques), Ichai, C. (Carole), Badenes, R. (R.), Prowle, J.R. (J. R.), Ercole, A. (Ari), Oddo, M. (Mauro), Schneider, A. (A.), Jagt, M. (Mathieu) van der, Wolf, S. (Stefan), Helbok, R. (Raimund), Nelson, D. (David), Skrifvars, M.B. (M. B.), Cooper, D.J. (D. J.), Bellomo, R. (R.), Long, K. (K.), Rodrigues, A. (A.), Lozano, A. (A.), Saxby, E. (E.), Vargiolu, A. (Alessia), Quintard, H. (H.), Robba, C. (C.), Sisson, A. (A.), Allen, G. (G.), Baro, N. (N.), and Kofler, M. (M.)
Abstract: Following publication of the original article [1], we were notified that the collaborators’ names part of the “The TBI Collaborative” group has not been indexed in Pubmed. Below the collaborators names full list: The TBI collaborative group: Long K (Intensive Care Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia), Rodrigues A
Published: 2019
Full Text: View/download PDF

85. Physical activity mediates the relationship between outdoor time and mental health

Author: Bélanger, M. (Mathieu), Gallant, F. (François), Doré, I. (Isabelle), O'Loughlin, J.L. (Jennifer L.), Sylvestre, M.-P. (Marie-Pierre), Abi Nader, P. (Patrick), Larouche, R. (Richard), Gunnell, K.E. (Katie E.), Sabiston, C.M. (Catherine M), Bélanger, M. (Mathieu), Gallant, F. (François), Doré, I. (Isabelle), O'Loughlin, J.L. (Jennifer L.), Sylvestre, M.-P. (Marie-Pierre), Abi Nader, P. (Patrick), Larouche, R. (Richard), Gunnell, K.E. (Katie E.), and Sabiston, C.M. (Catherine M)
Abstract: Both spending time outdoors and participating in physical activity improve mental health. Given that the outdoor environment provides an ideal location for physical activity, better understanding of the relationships among time spent outdoors, physical activity and positive mental health is needed to help guide interventions. The aim was to examine if physical activity moderates or mediates the relationship between outdoor time and positive mental health. Two-hundred-forty-two participants (15 ± 1 years old, 59% girls) from New Brunswick, Canada were included in the current analysis. Youth self-reported time spent outdoors and moderate-to-vigorous physical activity (MVPA) three times between October 2016 and June 2017. Data on their mental health were collected in October 2017. Values of outdoor time and MVPA were averaged across the three time points to represent the exposure and mediator variables, respectively. Mental health, dichotomized as flourishing/not flourishing, was the outcome in the mediation analysis. An interaction term tested if the mediation effect depended on outdoor time. Analyses were undertaken in 2019 using the mediation package in R. In univariate analyses, both MVPA (p < 0.001) and outdoor time (p = 0.05) were positive predictors of flourishing mental health. In mediation analyses, a small indirect mediation (OR: 1.02, 95% CI: 1.01–1.04) and no direct (1.00, 0.98–1.05) effect were noted, suggesting that MVPA mediates the effect of outdoor time on positive mental health. This effect did not vary as a function of outdoor time (interaction: 1.00, 0.99–1.01). Physical activity mediates the relationship between outdoor time and positive mental health. Outdoor time could promote positive mental health among youth through increases in physical activity.
Published: 2019
Full Text: View/download PDF

86. WGS-based telomere length analysis in Dutch family trios implicates stronger maternal inheritance and a role for RRM1 gene

Author: Nersisyan, L. (Lilit), Nikoghosyan, M. (Maria), Arakelyan, A. (Arsen), Francioli, L.C. (Laurent), Menelaou, A. (Androniki), Pulit, S.L. (Sara L.), Elbers, C.C. (Clara C.), Kloosterman, W.P. (Wigard), van Setten, J. (Jessica), Nijman, I.J. (Isaac), Renkens, I. (Ivo), de Bakker, P.I.W. (Paul I. W.), Dijk, F. (Freerk) van, Neerincx, P.B.T. (Pieter), Deelen, P. (Patrick), Kanterakis, A. (Alexandros), Dijkstra, M. (Martijn), Byelas, H. (Heorhiy), van der Velde, K.J. (K. Joeri), Platteel, M. (Mathieu), Swertz, M.A. (Morris A.), Wijmenga, C. (Cisca), Palamara, P.F. (Pier Francesco), Pe’er, I. (Itsik), Ye, K. (Kai), Lameijer, E.-W. (Eric-Wubbo), Moed, M.H. (Matthijs H.), Beekman, M. (Marian), Craen, A.J.M. (Anton) de, Suchiman, H.E.D. (H. Eka D.), Slagboom, P.E. (Eline), Guryev, V. (Victor), Abdellaoui, A. (Abdel), Jan Hottenga, J. (Jouke), Kattenberg, M. (Mathijs), Willemsen, G. (Gonneke), Boomsma, D.I. (Dorret), van Leeuwen, E.M. (Elisabeth M.), Karssen, L.C. (Lennart), Amin, N. (Najaf), Rivadeneira, F. (Fernando), Isaacs, A. (Aaron), Hofman, A. (Albert), Uitterlinden, A.G. (André), Duijn, C.M. (Cornelia) van, van Oven, M. (Mannis), Kayser, M. (Manfred), Vermaat, M. (Martijn), Laros, J.F.J. (Jeroen), Dunnen, J.T. (Johan) den, Enckevort, D. (David) van, Mei, H. (Hailiang), Li, M. (Mingkun), Stoneking, M. (Mark), Schaik, B.D.C. (Barbera) van, Bot, J. (Jan), Marschall, T. (Tobias), Schönhuth, A. (Alexander), Hehir-Kwa, J.Y. (Jayne), Handsaker, R.E. (Robert), Polak, P. (Paz), Sohail, M. (Mashaal), Vuzman, D. (Dana), Estrada, K. (Karol), McCarroll, S.A. (Steven A.), Sunyaev, S.R. (Shamil R.), Hormozdiari, F. (Fereydoun), Koval, V. (Vyacheslav), Medina-Gomez, C. (Carolina), Oostra, B. (Ben), Veldink, J. (Jan), van den Berg, L.H. (Leonard H.), Pitts, S.J. (Steven J.), Potluri, S. (Shobha), Sundar, P. (Purnima), Cox, D.R. (David R.), Knijff, P. (Peter) de, Li, Q. (Qibin), Li, Y. (Yingrui), Du, Y. (Yuanping), Chen, R. (Ruoyan), Cao, H. (Hongzhi), Wang, J. (Jun), Li, N. (Ning), Cao, S. (Sujie), Bovenberg, J.A. (Jasper), Ommen, G.-J.B. (Gert-Jan) van, The Genome of the Netherlands Consortium, Nersisyan, L. (Lilit), Nikoghosyan, M. (Maria), Arakelyan, A. (Arsen), Francioli, L.C. (Laurent), Menelaou, A. (Androniki), Pulit, S.L. (Sara L.), Elbers, C.C. (Clara C.), Kloosterman, W.P. (Wigard), van Setten, J. (Jessica), Nijman, I.J. (Isaac), Renkens, I. (Ivo), de Bakker, P.I.W. (Paul I. W.), Dijk, F. (Freerk) van, Neerincx, P.B.T. (Pieter), Deelen, P. (Patrick), Kanterakis, A. (Alexandros), Dijkstra, M. (Martijn), Byelas, H. (Heorhiy), van der Velde, K.J. (K. Joeri), Platteel, M. (Mathieu), Swertz, M.A. (Morris A.), Wijmenga, C. (Cisca), Palamara, P.F. (Pier Francesco), Pe’er, I. (Itsik), Ye, K. (Kai), Lameijer, E.-W. (Eric-Wubbo), Moed, M.H. (Matthijs H.), Beekman, M. (Marian), Craen, A.J.M. (Anton) de, Suchiman, H.E.D. (H. Eka D.), Slagboom, P.E. (Eline), Guryev, V. (Victor), Abdellaoui, A. (Abdel), Jan Hottenga, J. (Jouke), Kattenberg, M. (Mathijs), Willemsen, G. (Gonneke), Boomsma, D.I. (Dorret), van Leeuwen, E.M. (Elisabeth M.), Karssen, L.C. (Lennart), Amin, N. (Najaf), Rivadeneira, F. (Fernando), Isaacs, A. (Aaron), Hofman, A. (Albert), Uitterlinden, A.G. (André), Duijn, C.M. (Cornelia) van, van Oven, M. (Mannis), Kayser, M. (Manfred), Vermaat, M. (Martijn), Laros, J.F.J. (Jeroen), Dunnen, J.T. (Johan) den, Enckevort, D. (David) van, Mei, H. (Hailiang), Li, M. (Mingkun), Stoneking, M. (Mark), Schaik, B.D.C. (Barbera) van, Bot, J. (Jan), Marschall, T. (Tobias), Schönhuth, A. (Alexander), Hehir-Kwa, J.Y. (Jayne), Handsaker, R.E. (Robert), Polak, P. (Paz), Sohail, M. (Mashaal), Vuzman, D. (Dana), Estrada, K. (Karol), McCarroll, S.A. (Steven A.), Sunyaev, S.R. (Shamil R.), Hormozdiari, F. (Fereydoun), Koval, V. (Vyacheslav), Medina-Gomez, C. (Carolina), Oostra, B. (Ben), Veldink, J. (Jan), van den Berg, L.H. (Leonard H.), Pitts, S.J. (Steven J.), Potluri, S. (Shobha), Sundar, P. (Purnima), Cox, D.R. (David R.), Knijff, P. (Peter) de, Li, Q. (Qibin), Li, Y. (Yingrui), Du, Y. (Yuanping), Chen, R. (Ruoyan), Cao, H. (Hongzhi), Wang, J. (Jun), Li, N. (Ning), Cao, S. (Sujie), Bovenberg, J.A. (Jasper), Ommen, G.-J.B. (Gert-Jan) van, and The Genome of the Netherlands Consortium
Abstract: Telomere length (TL) regulation is an important factor in ageing, reproduction and cancer development. Genetic, hereditary and environmental factors regulating TL are currently widely investigated, however, their relative contribution to TL variability is still understudied. We have used whole genome sequencing data of 250 family trios from the Genome of the Netherlands project to perform computational measurement of TL and a series of regression and genome-wide association analyses to reveal TL inheritance patterns and associated genetic factors. Our results confirm that TL is a largely heritable trait, primarily with mother’s, and, to a lesser extent, with father’s TL having the strongest influence on the offspring. In this cohort, mother’s, but not father’s age at conception was positively linked to offspring TL. Age-related TL attrition of 40 bp/year had relatively small influence on TL variability. Finally, we have identified TL-associated variations in ribonuclease reductase catalytic subunit M1 (RRM1 gene), which is known to regulate telomere maintenance in yeast. We also highlight the importance of multivariate approach and the limitations of existing tools for the analysis of TL as a polygenic heritable quantitative trait.
Published: 2019
Full Text: View/download PDF

87. 'Abends zu einem Concert de Musique eingeladen'. Aspects musicaux du séjour parisien de Friedrich August II de Saxe

Author: Goulet, Anne-Madeleine, Campos, Rémy, da Vinha, Mathieu, Duron, Jean, Goulet, A ( Anne-Madeleine ), Campos, R ( Rémy ), da Vinha, M ( Mathieu ), Duron, J ( Jean ), Delpech, Louis, Goulet, Anne-Madeleine, Campos, Rémy, da Vinha, Mathieu, Duron, Jean, Goulet, A ( Anne-Madeleine ), Campos, R ( Rémy ), da Vinha, M ( Mathieu ), Duron, J ( Jean ), and Delpech, Louis
Published: 2019

88. A Custom Online Ultrasonic Gas Mixture Analyzer With Simultaneous Flowmetry, Developed for the Upgraded Evaporative Cooling System of the ATLAS Silicon Tracker

Author: B. DiGirolamo, P. Bonneau, G. Bozza, Steve McMahon, S. Katunin, C. Degeorge, J. Berthoud, E. Da Riva, J. Botelho-Direito, M. Battistin, M. Mathieu, G. D. Hallewell, A. Bitadze, Vic Vacek, Martin Doubek, Koichi Nagai, Cecile Deterre, G. Boyd, Richard Bates, Alexandre Rozanov, Lukasz Zwalinski, O. Crespo-Lopez, M. Vitek, Jan Godlewski, N. Langevin, N. Bousson, G. Favre, S. Berry, David Robinson, D. Lombard, and C. Rossi
Subjects: Physics, Nuclear and High Energy Physics, Spectrum analyzer, Silicon, business.industry, Octafluoropropane, chemistry.chemical_element, Flow measurement, chemistry.chemical_compound, Optics, Nuclear Energy and Engineering, chemistry, Hexafluoroethane, Water cooling, Ultrasonic sensor, Electrical and Electronic Engineering, business, Evaporative cooler
Abstract: We describe a combined ultrasonic instrument for continuous gas flow measurement and simultaneous real-time binary gas mixture analysis. In the instrument, sound bursts are transmitted in opposite directions, which may be aligned with the gas flow path or at an angle to it, the latter configuration being the best adapted to high flow rates. The combined flow measurement and mixture analysis algorithm exploits the phenomenon whereby the sound velocity in a binary gas mixture at known temperature and pressure is a unique function of the molar concentration of the two components. The instrument is central to a possible upgrade to the present ATLAS silicon tracker cooling system in which octafluoropropane (C F ) evaporative cooling fluid would be replaced by a blend containing up to 25% hexafluoroethane (C 2 F 6 ). The instrument has been developed in two geometries following computational fluid dynamics studies of various mechanical layouts. An instrument with 45 crossing angle has been installed for commissioning in the ATLAS silicon tracker cooling system. It can be used in gas flows up to 20 000 l.min -1 and has demonstrated a flow resolution of 2.3% of full scale for linear flow velocities up to 10 m.s in preliminary studies with air. Other instruments are currently used to detect low levels of C 2 F 8 vapor leaking into the N 2 environmental gas surrounding the ATLAS silicon tracker. A long-duration continuous study of more than a year has demonstrated a sensitivity to mixture variation of better than 5.10 -5 .
Published: 2014
Full Text: View/download PDF

89. Dix questions pratiques concernant l’intoxication aiguë au monoxyde de carbone chez la femme enceinte

Author: S. Joriot, Pascal Vaast, Damien Subtil, Raphael Favory, E. Bothuyne-Queste, E. Closset, Véronique Houfflin-Debarge, Daniel Mathieu, and M. Mathieu-Nolf
Subjects: Gynecology, medicine.medical_specialty, Pediatrics, Reproductive Medicine, Injury control, business.industry, Accident prevention, Obstetrics and Gynecology, Medicine, Poison control, General Medicine, business, Fetal damage
Abstract: Resume Position du probleme L’intoxication au monoxyde de carbone (CO) est la premiere cause de deces par intoxication en France. Ses consequences sont potentiellement graves pour le fœtus. La litterature est ancienne et peu connue. But et methode Faire un etat des lieux des connaissances concernant l’intoxication au CO pendant la grossesse. Resultat Le CO entraine une hypoxie tissulaire maternelle puis fœtale, principalement par fixation a l’hemoglobine avec laquelle il a une grande affinite. Son passage transplacentaire peut entrainer des lesions fœtales, principalement au niveau cerebral. Leur gravite semble correlee a la symptomatologie maternelle lors de l’exposition. En l’absence de symptomes maternels en revanche, les donnees dont nous disposons sont rassurantes. L’oxygenotherapie hyperbare pourrait reduire les risques fœtaux. Discussion L’oxygenotherapie devrait pouvoir etre proposee dans tous les cas d’intoxication au CO, en particulier s’il existe des symptomes maternels lors de l’exposition. Par ailleurs, une echographie fœtale orientee sur le pole cephalique – voire une imagerie par resonance magnetique fœtale trois semaines apres une exposition – devrait egalement etre proposee.
Published: 2014
Full Text: View/download PDF

90. Suicides par les plantes : à propos de 2 cas d’ingestion d’if et de laurier rose

Author: G. Choukroun, J. Poupon, I. Malissin, P. Nisse, J. Tison, and M. Mathieu
Subjects: 03 medical and health sciences, 0302 clinical medicine, Health, Toxicology and Mutagenesis, 010401 analytical chemistry, 030216 legal & forensic medicine, Toxicology, 01 natural sciences, 0104 chemical sciences
Abstract: Objectif Les intoxications par les plantes sont le plus souvent accidentelles par defaut de perception du risque ou par confusion alimentaire avec une espece comestible. En France, les suicides par ingestion de plantes restent rares. Nous rapportons 2 suicides par ingestion de feuilles de laurier rose et d’If. Descriptions des cas Cas no 1 : les pompiers interviennent en foret pour prendre en charge un homme de 53 ans presentant un malaise avec vomissements. Il revele avoir ingere une infusion de feuilles de laurier rose avec du pastis. Le patient est conscient, Glasgow 15, bradycardie a 40/min et hypotension arterielle a 70/40 mmHg. L’ECG retrouve une bradycardie sinusale avec un BAV du 1er degre et un trouble de la repolarisation avec un ST en cupule en DII, DIII, aVL, V3 a V6. Apres un remplissage et l’administration d’atropine, il est dirige vers le service de reanimation ou lui seront administres 400 mg de Digifab® a 2 reprises. L’evolution est marquee par l’installation d’une insuffisance circulatoire complique secondairement d’un arret cardiaque sur fibrillation ventriculaire refractaire aux tentatives de defibrillation et aux bolus d’adrenaline. Malgre la mise en place d’une assistance circulatoire par ECMO, l’evolution sera rapidement fatale dans un tableau de defaillance multi-viscerale. Cas no 2 : un homme de 34 ans est hospitalise pour une tentative de suicide par ingestion supposee d’alimemazine, d’oxazepam et d’alcool. L’evolution etant rapidement favorable, il est transfere en « lit porte » ou il en profite pour boire une infusion de laurier rose et des feuilles d’if prealablement mixees. Il va presenter des vomissements puis un 1er arret cardiaque sur fibrillation ventriculaire. Il va recevoir successivement du bicarbonate molaire, du gluconate de calcium, des bolus d’adrenaline, du sulfate de magnesium et 80 mg de digifab®. Il sera transfere en reanimation toxicologique pour mise en place d’une assistance circulatoire dans un contexte d’arret cardiaque refractaire. Il va presenter un etat de choc post ressuscitation avec syndrome de fuite capillaire aboutissant a son deces. Resultats Cas 1 : la digoxinemie est dosee a 0,98 ng/mL (estimation oleandrinemie 4,1 μg/mL) [1] , recherche de toxiques sang et urines negative. Cas 2, digoxinemie a 2,68 ng/mL (estimation [1] oleandrinemie 11,2 μg/mL), citalopram a 0,23 mg/L, diazepam a 0,13 mg/L, presence de lamotrigine et de perindopril. Les taxines ne sont pas recherchees. Conclusion La frequence des intoxications par les plantes toxiques est estimee a 1,5 % en France. Les suicides par les plantes sont tres rares sur l’hexagone. La toxicite du laurier rose est due a la presence d’heterosides cardiotoniques, dont l’oleandrine, de structure proche de celle des digitaliques. La toxicite de l’if est due a la presence de taxines, notamment taxine A, taxine B et la baccatine. La taxine B possede des proprietes cardiotoxiques directes. Les modes de preparation sont souvent les memes, infusion, decoction ou mixage parfois associes comme dans le cas 2. Au moins un site sur internet, « the suicide method file, V2.0 » donne les renseignements necessaires pour reussir son suicide en utilisant des plantes (ou des champignons).
Published: 2018
Full Text: View/download PDF

91. Intoxication au chlorméquat : et si l’atropine et la néostogmine étaient le traitement antidotique ?

Author: J. Langrand, R. Azzouz, Patrick Nisse, and M. Mathieu-Nolf
Subjects: 03 medical and health sciences, 0302 clinical medicine, Health, Toxicology and Mutagenesis, 010401 analytical chemistry, 030216 legal & forensic medicine, Toxicology, 01 natural sciences, 0104 chemical sciences
Abstract: Introduction Le chlorure de chlormequat appartenant a la famille des ammoniums quaternaires est utilise comme substance active de produits phytopharmaceutiques en tant que regulateur de croissance. Si les expositions accidentelles sont generalement benignes, les tentatives de suicide sont quant a elles souvent fatales. Nous avions deja publie une premiere serie de 7 deces dans la region des Hauts-de-France [1] . Plus recemment, nous avons eu a gerer 3 nouvelles tentatives de suicide dont l’une avec une issue favorable qui nous ont amene a reflechir sur une eventuelle prise en charge antidotique. Cas cliniques Cas no 1 : un jeune homme de 27 ans qui aurait ingere 120 mL d’une preparation phytopharmaceutique (PPP) est retrouve inconscient 6 h apres l’ingestion. Malgre l’intervention de l’equipe medicale, le patient est declare decede a son domicile. Cas no 2 : une jeune femme de 33 ans qui aurait ingere 70 mL d’une PPP est retrouvee 2 h plus tard, inconsciente avec des fasciculations, en sueur, en arret cardiaque par son pere qui entreprend un massage cardiaque externe en attendant les secours. La guerison de la patiente est obtenue en 48 h. Cas no 3 : un homme de 47 ans a un accident de la circulation apres avoir ingere 250 mL d’une PPP. Lors de sa prise en charge, il est dans le coma (Glasgow 3) avec une defaillance respiratoire puis secondairement une defaillance des fonctions hepatique et renale qui aboutissent au deces du patient. Discussion La denomination chimique du chlormequat est le 2-chloroethyl trimethylammonium chloride. Son absorption par voie digestive est quasi complete (> 90 %), il est ensuite distribue dans le foie et les reins ; il est ensuite elimine sous forme inchangee (pour 97 % de la dose absorbee) dans les urines. Si le tableau clinique de l’intoxication est evocateur d’une intoxication par une substance anticholinesterasique (bradycardie, myosis, bradypnee ou paralysie respiratoire, hypersudation), le chlormequat n’est pas un inhibiteur des cholinesterases. Compte tenu de sa structure chimique, le chlormequat a possiblement des proprietes curare-like, il est aussi responsable d’une symptomatologie cholinergique par son action directe sur les recepteurs nicotiniques (blocage) et muscariniques (stimulation). Le chlormequat semble agir comme un agoniste partiel de l’acetylcholine provoquant une depolarisation prolongee de la plaque motrice terminale, notamment au niveau du diaphragme contribuant a la detresse respiratoire. Son effet se rapproche de celui du decamethonium ou de la succinylcholine [2] . Par consequent, il pourrait etre interessant, en theorie, d’administrer de faibles doses d’atropine des l’apparition des signes cholinergiques pour antagoniser les effets cholinergiques et d’administrer conjointement de faibles doses de neostigmine pour contrecarrer les effets curare-like du chlormequat. Conclusion Compte tenu de l’extreme gravite des tentatives de suicide par ingestion de chlormequat avec un engagement du pronostic vital dans l’heure qui suit l’ingestion, il serait interessant de proposer l’utilisation de faibles doses d’atropine et de neostigmine lors de la prise en charge de patient intoxique au chlormequat.
Published: 2019
Full Text: View/download PDF

92. FLNC mutations in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations

Author: F. Ader, Caroline Rooryck-Thambo, Albert A. Hagège, Claire Perret, Marion Gérard, L. Van Maldergem, Diala Khraiche, P. De Groote, Eric Villard, Y. Troadec, Xavier Jeunemaitre, Pascale Richard, P. Reant, P. Charron, Caroline Rambaud, Jean François Pruny, D. Dupin Deguine, Laurent Gouya, and M. Mathieu Dramard
Subjects: medicine.medical_specialty, business.industry, Cardiomyopathy, Dilated cardiomyopathy, medicine.disease, Sudden cardiac death, Internal medicine, Heart failure, Medicine, Missense mutation, FLNC, Family history, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Myopathy
Abstract: Introduction Mutations in FLNC encoding filamin C have been firstly reported to cause dominant myofibrillar and distal myopathy. More recently, dominant pathogenic variants in FLNC have also been linked to the development of isolated cardiac phenotypes. Objective Only few publications on cohorts with FLNC pathogenic variants are published and the pathophysiology of FLNC-related cardiomyopathy is poorly understood. The aim of this retrospective study is to establish the prevalence of mutation in the FLNC gene in the different subtypes of cardiomyopathies and search for genotype-phenotype associations. Methods DNAs from a cohort of 1150 unrelated index-patients with an isolated cardiomyopathy (700 hypertrophic, 300 dilated, 50 restrictive cardiomyopathies, and 100 left ventricle non-compactions) have been sequenced on a custom panel of 52 cardiomyopathy disease-causing genes. Results A FLNC pathogenic mutation was identified in 28 patients corresponding to a prevalence ranging from 1 to 8% depending on the cardiomyopathy subtypes. Truncating mutations were always identified in patients with dilated cardiomyopathy, while mis-sense or in-frame mutations were found in other phenotypes. In the cohort, nine patients (32%) were implanted with an automatic defibrillator. In 7 families (25%), history of sudden cardiac death (SCD) before 50 years was reported. A personal or family history of SCD was significantly higher in patients with truncating variants than in patients carrying missense variants (P = 0.01). Acute heart failure was observed in 7 patients (25%). Four patients died of cardiac cause including 3 from SCD and 1 from heart failure. Conclusion This work highlights the role of FLNCin studied cardiomyopathy subtypes. A correlation between the type of the mutation and the cardiomyopathy subtype was observed as well as with SCD risk. These new data should be taken into consideration for patient's management and primary prevention of sudden cardiac death.
Published: 2019
Full Text: View/download PDF

93. Les lois de programmation des finances publiques. Un instrument de pilotage souple façonné par les parlementaires

Author: Peruyero, M. Mathieu, primary
Published: 2019
Full Text: View/download PDF

94. Chlormequat poisoning is not without risk: Examination of seven fatal cases

Author: P.A. Mielcarek, P. Nisse, R. Majchrzak, M. Mathieu-Nolf, and J.Ph. Kahn
Subjects: Adult, Male, Adolescent, Chlormequat, Multiple Organ Failure, Physiology, Poison control, Pathology and Forensic Medicine, Toxicology, Forensic Toxicology, chemistry.chemical_compound, Plant Growth Regulators, Muscarinic acetylcholine receptor, Accidents, Occupational, Humans, Ingestion, Medicine, Retrospective Studies, Cholinesterase, biology, business.industry, Forensic toxicology, General Medicine, Middle Aged, Heart Arrest, Suicide, Nicotinic agonist, chemistry, biology.protein, Cholinergic, Respiratory Insufficiency, business, Law
Abstract: Chlormequat chloride is a plant growth regulator. Chlormequat poisoning clinically resembles anticholinesterase insecticide poisoning. The cholinergic symptoms result from direct action on nicotinic and muscarinic receptors and not from inhibition of the cholinesterase activity. This case series confirms the extreme gravity of chlomequat poisoning with a risk of death in the hour following ingestion.
Published: 2015
Full Text: View/download PDF

95. COMMENT REDOUBLER D'EFFORTS FACE À UNE DOUBLE CRISE ?

Author: Laneuville, M. Mathieu and Pigeon, Mme Geneviève
Published: 2024

96. The phenotypic spectrum of WWOX -related disorders: 20 additional cases of WOREE syndrome and review of the literature

Author: Piard, J. (Juliette), Hawkes, L. (Lara), Milh, M. (Mathieu), Villard, L. (Laurent), Borgatti, R. (Renato), Romaniello, R. (Romina), Fradin, M. (Melanie), Capri, Y. (Yline), Héron, D. (Delphine), Nougues, M.-C. (Marie-Christine), Nava, C. (Caroline), Arsene, O.T. (Oana Tarta), Shears, D.J. (Deborah), Sogawa, Y. (Yoshimi), Johnson, D. (David), Firth, H.V., Vasudevan, P. (Pradeep), Jones, G. (Gabriela), Nguyen-Morel, M.-A. (Marie-Ange), Busa, T. (Tiffany), Roubertie, A. (Agathe), Born, M. (Myrthe) van den, Brischoux-Boucher, E. (Elise), Koenig, M. (Michel), Mignot, C. (Cyril), Kini, U. (Usha), Philippe, C. (Christophe), Piard, J. (Juliette), Hawkes, L. (Lara), Milh, M. (Mathieu), Villard, L. (Laurent), Borgatti, R. (Renato), Romaniello, R. (Romina), Fradin, M. (Melanie), Capri, Y. (Yline), Héron, D. (Delphine), Nougues, M.-C. (Marie-Christine), Nava, C. (Caroline), Arsene, O.T. (Oana Tarta), Shears, D.J. (Deborah), Sogawa, Y. (Yoshimi), Johnson, D. (David), Firth, H.V., Vasudevan, P. (Pradeep), Jones, G. (Gabriela), Nguyen-Morel, M.-A. (Marie-Ange), Busa, T. (Tiffany), Roubertie, A. (Agathe), Born, M. (Myrthe) van den, Brischoux-Boucher, E. (Elise), Koenig, M. (Michel), Mignot, C. (Cyril), Kini, U. (Usha), and Philippe, C. (Christophe)
Abstract: Purpose: Germline WWOX pathogenic variants have been associated with disorder of sex differentiation (DSD), spinocerebellar ataxia (SCA), and WWOX-related epileptic encephalopathy (WOREE syndrome). We review clinical and molecular data on WWOX-related disorders, further describing WOREE syndrome and phenotype/genotype correlations. Methods: We report clinical and molecular findings in 20 additional patients from 18 unrelated families with WOREE syndrome and biallelic pathogenic variants in the WWOX gene. Different molecular screening approaches were used (quantitative polymerase chain reaction/multiplex ligation-dependent probe amplification [qPCR/MLPA], array comparative genomic hybridization [array-CGH], Sanger sequencing, epilepsy gene panel, exome sequencing). Results: Two copy-number variations (CNVs) or two single-nucleotide variations (SNVs) were found respectively in four and nine families, with compound heterozygosity for one SNV and one CNV in five families. Eight novel missense pathogenic variants have been described. By aggregating our patients with all cases reported in the literature, 37 patients from 27 families with WOREE syndrome are known. This review suggests WOREE syndrome is a very severe epileptic encephalopathy characterized by absence of language development and acquisition of walking, early-onset drug-resistant seizures, ophthalmological involvement, and a high likelihood of premature death. The most severe clinical presentation seems to be associated with null genotypes. Conclusion: Germline pathogenic variants in WWOX are clearly associated with a severe early-onset epileptic encephalopathy. We report here the largest cohort of individuals with WOREE syndrome.
Published: 2018
Full Text: View/download PDF

97. Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: A phase II safety and feasibility study

Author: Islam, M.B. (Mohammad Badrul), Islam, Z. (Zhahirul), Rahman, S. (Shafiqur), Endtz, H.P. (Hubert), Vos, M.C. (Margreet C), Jagt, M. (Mathieu) van der, Van Doorn, P.A. (Peter A), Jacobs, B.C. (Bart), Mohammad, Q.D. (Quazi), Islam, M.B. (Mohammad Badrul), Islam, Z. (Zhahirul), Rahman, S. (Shafiqur), Endtz, H.P. (Hubert), Vos, M.C. (Margreet C), Jagt, M. (Mathieu) van der, Van Doorn, P.A. (Peter A), Jacobs, B.C. (Bart), and Mohammad, Q.D. (Quazi)
Abstract: Objective To assess the safety and feasibility of small volume plasma exchange (SVPE) for patients with Guillain-Barré syndrome (GBS). Design Non-randomised, single-arm, interventional trial. Setting National Institute of Neurosciences and Hospital, Dhaka, Bangladesh. Participants Twenty adult (>18 years) patients with GBS presented within 2 weeks of onset of weakness who were unable to walk unaided for more than 10 m. Interventions SVPE involves blood cell sedimentation in a blood bag and removal of supernatant plasma after blood cells are retransfused. This procedure was repeated three to six times a day, for eight consecutive days. Fresh frozen plasma (FFP) and normal saline were used as replacement fluid. Outcome measures Serious adverse events (SAEs) were defined as severe sepsis and deep venous thrombosis related to the central venous catheter (CVC) used during SVPE. SVPE was considered safe if less than 5/20 patients experienced an SAE, and feasible if 8 L plasma could be removed within 8 days in at least 15/20 patients. Results Median patient age 33 years (IQR 23-46; range 18-55); 13 (65%) were male. Median Medical Research Council (MRC) sum score was 20 (IQR 0-29; range 0-36); three (15%) patients required mechanical ventilation. One patient developed SAE (severe sepsis, possibly related to CVC). The median plasma volume exchanged was 140 mL/kg (range 110-175) and removal of 8 L plasma was possible in 15 (75%) patients. Patients received a median 1 g/kg IgG via FFP although a substantial proportion of IgG was probably removed again by the SVPE sessions. GBS disability score improved by at least one grade in 14 (70%) patients 4 weeks after SVPE started. No patients died. Conclusion SVPE seems a safe and feasible alternative treatment to standard plasma exchange (PE) or intravenous immunoglobulin (IVIg) for GBS; further studies of clinical efficacy in low-income and middle-income countries are warranted. Trial registration number NCT02780570.
Published: 2018
Full Text: View/download PDF

98. Brain death and postmortem organ donation: report of a questionnaire from the CENTER-TBI study

Author: van Veen, E. (Ernest), Jagt, M. (Mathieu) van der, Cnossen, M.C. (Maryse), Maas, A.I.R. (Andrew), Beaufort, I.D. (Inez) de, Menon, D.K. (David ), Citerio, G. (Giuseppe), Stocchetti, N. (Nino), Rietdijk, W.J.R. (Wim), van Dijck, J.T.J.M. (Jeroen T J M), Kompanje, E.J.O. (Erwin), van Veen, E. (Ernest), Jagt, M. (Mathieu) van der, Cnossen, M.C. (Maryse), Maas, A.I.R. (Andrew), Beaufort, I.D. (Inez) de, Menon, D.K. (David ), Citerio, G. (Giuseppe), Stocchetti, N. (Nino), Rietdijk, W.J.R. (Wim), van Dijck, J.T.J.M. (Jeroen T J M), and Kompanje, E.J.O. (Erwin)
Abstract: BACKGROUND: We aimed to investigate the extent of the agreement on practices around brain death and postmortem organ donation. METHODS: Investigators from 67 Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study centers completed several questionnaires (response rate: 99%). RESULTS: Regarding practices around brain death, we found agreement on the clinical evaluation (prerequisites and neurological assessment) for brain death determination (BDD) in 100% of the centers. However, ancillary tests were required for BDD in 64% of the centers. BDD for nondonor patients was deemed mandatory in 18% of the centers before withdrawing life-sustaining measures (LSM). Also, practices around postmortem organ donation varied. Organ donation after circulatory arrest was forbidden in 45% of the centers. When withdrawal of LSM was contemplated, in 67% of centers the patients with a ventricular drain in situ had this removed, either sometimes or all of the time. CONCLUSIONS: This study showed both agreement and some regional
Published: 2018
Full Text: View/download PDF

99. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage a randomized clinical trial

Author: Gathier, C.S. (Celine S.), Van Den Bergh, H. (Huub), Jagt, M. (Mathieu) van der, Verweij, B.H., Dankbaar, J.W. (Jan), Müller, M.C. (Marcella), Oldenbeuving, A.W., Rinkel, G.J.E. (Gabriel), Slooter, A.J.C. (Arjen), Gathier, C.S. (Celine S.), Van Den Bergh, H. (Huub), Jagt, M. (Mathieu) van der, Verweij, B.H., Dankbaar, J.W. (Jan), Müller, M.C. (Marcella), Oldenbeuving, A.W., Rinkel, G.J.E. (Gabriel), and Slooter, A.J.C. (Arjen)
Abstract: Background and Purpose-Induced hypertension is widely used to treat delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage, but a literature review shows that its presumed effectiveness is based on uncontrolled caseseries only. We here report clinical outcome of aneurysmal subarachnoid hemorrhage patients with DCI included in a randomized trial on the effectiveness of induced hypertension. Methods-Aneurysmal subarachnoid hemorrhage patients with clinical symptoms of DCI were randomized to induced hypertension or no induced hypertension. Risk ratios for poor outcome (modified Rankin Scale score >3) at 3 months, with 95% confidence intervals, were calculated and adjusted for age, clinical condition at admission and at time of DCI, and amount of blood on initial computed tomographic scan with Poisson regression analysis. Results-The trial aiming to include 240 patients was ended, based on lack of effect on cerebral perfusion and slow recruitment, when 21 patients had been randomized to induced hypertension, and 20 patients to no hypertension. With induced hypertension, the adjusted risk ratio for poor outcome was 1.0 (95% confidence interval, 0.6-1.8) and the risk ratio for serious adverse events 2.1 (95% confidence interval, 0.9-5.0). Conclusions-Before this trial, the effectiveness of induced hypertension for DCI in aneurysmal subarachnoid hemorrhage patients was unknown because current literature consists only of uncontrolled case series. The results from our premature halted trial do not add any evidence to support induced hypertension and show that this treatment can lead to serious adverse events.
Published: 2018
Full Text: View/download PDF

100. Reinventing Liberalism

Author: Kooten, M. (Mathieu) van and Kooten, M. (Mathieu) van
Abstract: In this article I describe how neoliberal hegemony is a deeply disseminated governing rationality that puts the economy at the centre of society, its institutions, and human understanding and action. I argue that if neoliberal rationality and the homo economicus remain at the centre of human understanding and action, the erosion of the institutions, values, and morality organised by non-market rationalities will persevere. I approach this problem by exploring the essentially Christian roots through which the modern Western individual was invented. The acknowledgement and understanding of these religious and moral roots can open up a new perspective of reinventing liberalism and formulating a comprehensive morality for the future.
Published: 2018

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

1,366 results on '"M, Mathieu"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources